Neisseria gonorrhoeae 89-018314 is a microaerophile, Gram-negative, coccus-shaped bacterium of the family Neisseriaceae.
Gram-negative coccus-shaped microaerophile genome sequence 16S sequence Bacteria| @ref 20215 |
|
Last LPSN update
2026-05-29 08:27:20 |
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Betaproteobacteria |
| Order Neisseriales |
| Family Neisseriaceae |
| Genus Neisseria |
| Species Neisseria gonorrhoeae |
| Full scientific name Neisseria gonorrhoeae (Zopf 1885) Trevisan 1885 (Approved Lists 1980) |
| Synonyms (1) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 3508 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive  | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 36023 | MEDIUM 10 - Chocolate medium for Actinobacillus pleuropneumoniae, Capnocytophaga cynodegmi, Haemophilus and Neisseria | Distilled water make up to (1000.000 ml);Columbia agar (39.000 g);Horseblood (100.000 ml);PolyVitex mischung (10.000 ml) | |||
| 119706 | CIP Medium 10 | Medium recipe at CIP |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 119706 | 606565 ChEBI | hippurate | - | hydrolysis | |
| 68377 | 17306 ChEBI | maltose | - | builds acid from | from API NH |
| 119706 | 17632 ChEBI | nitrate | - | builds gas from | |
| 119706 | 17632 ChEBI | nitrate | - | reduction | |
| 119706 | 16301 ChEBI | nitrite | - | builds gas from | |
| 119706 | 16301 ChEBI | nitrite | - | reduction | |
| 68377 | 18257 ChEBI | ornithine | - | degradation | from API NH |
| 68377 | 17992 ChEBI | sucrose | - | builds acid from | from API NH |
| 68377 | 27897 ChEBI | tryptophan | - | energy source | from API NH |
| 68377 | 16199 ChEBI | urea | - | hydrolysis | from API NH |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 119706 | alcohol dehydrogenase | - | 1.1.1.1 | |
| 68382 | alkaline phosphatase | - | 3.1.3.1 | from API zym |
| 68377 | alkaline phosphatase | - | 3.1.3.1 | from API NH |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 119706 | amylase | - | ||
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 119706 | beta-galactosidase | + | 3.2.1.23 | |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 119706 | caseinase | - | 3.4.21.50 | |
| 3508 | catalase | + | 1.11.1.6 | |
| 119706 | catalase | + | 1.11.1.6 | |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 3508 | cytochrome-c oxidase | + | 1.9.3.1 | |
| 119706 | DNase | - | ||
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 119706 | gamma-glutamyltransferase | - | 2.3.2.2 | |
| 119706 | gelatinase | - | ||
| 119706 | lecithinase | - | ||
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 119706 | lipase | - | ||
| 68377 | lipase | - | from API NH | |
| 68382 | lipase (C 14) | - | from API zym | |
| 119706 | lysine decarboxylase | - | 4.1.1.18 | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | - | from API zym | |
| 119706 | ornithine decarboxylase | - | 4.1.1.17 | |
| 68377 | ornithine decarboxylase | - | 4.1.1.17 | from API NH |
| 119706 | oxidase | + | ||
| 119706 | protease | - | ||
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 68377 | tryptophan deaminase | - | 4.1.99.1 | from API NH |
| 119706 | tween esterase | - | ||
| 119706 | urease | - | 3.5.1.5 | |
| 68377 | urease | - | 3.5.1.5 | from API NH |
| 68382 | valine arylamidase | - | from API zym |
| @ref | PEN | GLU | FRU | MAL | SAC | ODC | URE | LIP | PAL | beta GAL | ProA | GGT | IND | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3508 | - | + | - | - | - | - | - | - | - | - | + | - | - | |
| 3508 | - | + | - | - | - | - | - | - | - | - | + | + | - | |
| 48390 | - | + | - | - | - | - | - | - | - | - | + | - | - | |
| 3508 | + | - | - | - | - | - | - | - | - | + | - | - | - | |
| 3508 | + | - | - | - | - | - | - | - | - | + | - | - | - | |
| 3508 | + | - | - | - | - | - | - | - | - | + | - | - | - | |
| 3508 | + | - | - | - | - | - | - | - | - | + | - | - | - | |
| 3508 | + | - | - | - | - | - | - | - | - | + | - | - | - | |
| 3508 | - | + | +/- | - | - | - | - | - | - | - | + | - | - | |
| 3508 | - | + | - | - | - | - | - | - | - | - | + | - | - | |
| 3508 | - | + | - | - | - | - | - | - | - | - | + | - | - | |
| 3508 | - | + | - | - | - | - | - | - | - | - | + | - | - | |
| 3508 | - | + | - | - | - | - | - | - | - | - | + | - | - | |
| 3508 | - | + | - | - | - | - | - | - | - | - | + | - | - |
Global distribution of 16S sequence GU395613 (>99% sequence identity) for Neisseria gonorrhoeae subclade from Microbeatlas 
 Aquatic Samples |
208 |
 Soil Samples |
26 |
 Animal Samples |
3447 |
 Plant Samples |
13 |
| Total Samples | 3694 |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|
| 66792 | ASM2517121v2 assembly for Neisseria gonorrhoeae ATCC 49226 | complete | GCA_025171215   | 485.18004  | 485 | 98.62 | |
| 66792 | ASM1680389v1 assembly for Neisseria gonorrhoeae ATCC 49226 | chromosome | GCA_016803895 | 485.9871 | 485 | 88.62 | |
| 66792 | Neisseria gonorrhoeae strain ATCC49226 | contig | 485.866 | 485 | 65.8 | | |
| 66792 | ASM199764v1 assembly for Neisseria gonorrhoeae ATCC 49226 | scaffold | GCA_001997645 | 485.877 | 485 | 42.55 | |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 20218 | Neisseria gonorrhoeae strain ATCC 49226 16S ribosomal RNA gene, complete sequence | GU395612 | 1544 |  | 485 | |
| 20218 | Neisseria gonorrhoeae strain 49226mut_SPC 16S ribosomal RNA gene, complete sequence | GU395613 | 1544 | | 485 | |
| 124043 | Neisseria gonorrhoeae 16S rRNA gene, partial | AJ247239 | 457 | | 485 | |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Phylogeny | Diagnostics of neisseriaceae and moraxellaceae by ribosomal DNA sequencing: ribosomal differentiation of medical microorganisms. | Harmsen D, Singer C, Rothganger J, Tonjum T, de Hoog GS, Shah H, Albert J, Frosch M. | J Clin Microbiol | 10.1128/jcm.39.3.936-942.2001 | 2001 | |
| Nourseothricin as a novel therapeutic agent against Neisseria gonorrhoeae: in vitro and in vivo evaluations using Galleria mellonella-a pilot study. | Kanesaka I, Abdellati S, Gestels Z, Vanbaelen T, De Baetselier I, de Block T, Manoharan-Basil SS, Kenyon C. | Microbiol Spectr | 10.1128/spectrum.01275-25 | 2025 | | |
| In-vitro Activities of Zoliflodacin and Solithromycin Against Neisseria gonorrhoeae Isolates from Korea. | Roh KH, Luong ND, Liu C, Seo YH, Lee H, Unemo M, Lee K. | Ann Lab Med | 10.3343/alm.2024.0522 | 2025 | | |
| Differential contribution of PBP occupancy and efflux on the effectiveness of beta-lactams at their target site in clinical isolates of Neisseria gonorrhoeae. | Lopez-Arguello S, Alcoceba E, Ordonez P, Taltavull B, Cabot G, Gomis-Font MA, Oliver A, Moya B. | PLoS Pathog | 10.1371/journal.ppat.1012783 | 2024 | | |
| Enzymology | The bactericidal FabI inhibitor Debio 1453 clears antibiotic-resistant Neisseria gonorrhoeae infection in vivo. | Gerusz V, Regenass P, Rousseau Q, Moraine V, Dao J, Lave X, Das S, Hue Perron J, Fajas Descamps L, Bravo J, Dieppois G, Kaplan N, Lefebre M, Altomari D, Romanov V, Finn T, Daram P, Bernardini F, Gross M, Lysek R, Adam A, Pohin D, Maio M, Tatsis V, Sunose M, Ronin C, Ciesielski F, Ahlstrand J, Jacobsson S, Unemo M, Cameron DR. | Nat Commun | 10.1038/s41467-025-63508-w | 2025 | |
| Stability of Spiked Chlamydia Trachomatis and Neisseria Gonorrhea in Urine and Swab Specimens After Prolonged Storage at Room and Freezer Temperatures Using Aptima Combo-2 Test. | Stankiewicz Karita HC, Magaret AS, Selke S, Pascual R, Irimia B, Barbee LA, Wald A, Soge OO. | Open Forum Infect Dis | 10.1093/ofid/ofaf388 | 2025 | | |
| Genetics | Genomic trends and emerging antimicrobial resistance in Neisseria gonorrhoeae over two decades in Kenya. | Mehta SD, Thorington R, Agingu W, Otieno F, Unitt A, Rusie LK, Le Van A, Martin I, Jerse AE, Harrison O. | Microbiol Spectr | 10.1128/spectrum.01586-25 | 2025 | |
| Effect of 13 traditional Chinese medicine drug preparations against Neisseria gonorrhoeae. | Liao W, Zhou K, Zhang Y, Huang Y, Zhang X, Yin Y, Zhou Q, Chen S, Li W, Xu W. | Front Pharmacol | 10.3389/fphar.2025.1694041 | 2025 | | |
| Bacitracin enhances ceftriaxone susceptibility of the high-level ceftriaxone-resistant gonococcal FC428 clone. | Gu Y, Song S, Zhu Q, Jiao R, Lin X, Yang F, van der Veen S. | Microbiol Spectr | 10.1128/spectrum.02449-23 | 2023 | | |
| Evaluating Chelerythrine Chloride as a Potential Treatment for Multidrug-Resistant Gonorrhea. | Zhang R, Qi Y, Peng H, Tao C, Lu S, Ke Q, Shen S, Wang Z, Lin X. | Infect Drug Resist | 10.2147/idr.s538954 | 2025 | | |
| Neisseria gonorrhoeae antimicrobial susceptibility testing: application of traditional agar dilution to a high-throughput 96-well microtiter assay. | Kuipers JE, Seidel L, Garnier NE, Khursigara CM. | Microbiol Spectr | 10.1128/spectrum.03249-24 | 2025 | | |
| Antimicrobial resistance in Neisseria gonorrhoeae in nine sentinel countries within the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2023: a retrospective observational study. | Maatouk I, Vumbugwa P, Cherdtrakulkiat T, Heng LS, Hoffman I, Palaypayon N, Kakooza F, Kittiyaowamarn R, Kyambadde P, Lahra MM, Lan PT, Maseko V, Matoga M, Machiha A, Muller E, Nguyen TTP, Doanh LH, Ouk V, Setiawaty V, Sia SB, Hartono TS, Virak M, Thuy Van NT, Unemo M, Wi T, WHO EGASP Study Group. | Lancet Reg Health West Pac | 10.1016/j.lanwpc.2025.101663 | 2025 | | |
| High susceptibility to the novel antimicrobial zoliflodacin among Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024. | Jacobsson S, Cherdtrakulkiat T, Golparian D, Heng LS, Hoffman I, Jamoralin MC, Kakooza F, Kittiyaowamarn R, Kyambadde P, Lan PT, Maseko V, Matoga M, Muller E, Nguyen TTP, Ouk V, Schroder D, Setiawaty V, Sia SB, Sulaiman V, Virak M, Van NTT, Maatouk I, Wi T, Unemo M, WHO EGASP zoliflodacin study group. | IJID Reg | 10.1016/j.ijregi.2025.100624 | 2025 | | |
| Therapeutic potential of botanical drugs and their metabolites in the treatment of pelvic inflammatory disease. | Zhong HZ, Yan PJ, Gao QF, Wu J, Ji XL, Wei SB. | Front Pharmacol | 10.3389/fphar.2025.1545917 | 2025 | | |
| Antimicrobial susceptibility surveillance and antimicrobial resistance in Neisseria gonorrhoeae in Africa from 2001 to 2020: A mini-review. | Kakooza F, Kiggundu R, Mboowa G, Kateete PD, Nsangi OT, Kabahita JM, Ssentalo Bagaya B, Golparian D, Unemo M. | Front Microbiol | 10.3389/fmicb.2023.1148817 | 2023 | | |
| In vitro susceptibility of Neisseria gonorrhoeae to netilmicin and etimicin in comparison to gentamicin and other aminoglycosides. | Gross S, Herren S, Gysin M, Rominski A, Roditscheff A, Risch M, Imkamp F, Crich D, Hobbie SN. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-024-04782-2 | 2024 | | |
| Gonococcal OMV-delivered PorB induces epithelial cell mitophagy. | Gao S, Gao L, Yuan D, Lin X, van der Veen S. | Nat Commun | 10.1038/s41467-024-45961-1 | 2024 | | |
| The burden of Neisseria gonorrhoeae infection, risky sexual behavior, and associated risk factors among sexually transmitted infections in a resource-limited setting area of Addis Ababa City, Ethiopia. | Andualem T, Belay G, Desta AF, Nigussie H, Mulu W, Desalegn A, Taddesse G, Mekonen Y, Beyene D. | Front Reprod Health | 10.3389/frph.2025.1601088 | 2025 | | |
| Penicillin-Binding Protein Occupancy Dataset for 18 beta-Lactams and 4 beta-Lactamase Inhibitors in Neisseria gonorrhoeae. | Lopez-Arguello S, Montaner M, Marmol-Salvador A, Velazquez-Escudero A, Docobo-Perez F, Oliver A, Moya B. | Microbiol Spectr | 10.1128/spectrum.00692-23 | 2023 | | |
| Breakthrough Rectal Neisseria gonorrhoeae Infections After Meningococcal B Vaccination: Microbiological and Clinical Features. | Raccagni AR, Diotallevi S, Lolatto R, Bruzzesi E, Garcia Martearena MDC, Mainardi I, Candela C, Canetti D, Piromalli G, Clementi N, Burioni R, Castagna A, Nozza S. | Open Forum Infect Dis | 10.1093/ofid/ofae562 | 2024 | | |
| Antimicrobial effects of Medicines for Malaria Venture Pathogen Box compounds on strains of Neisseria gonorrhoeae. | Mensah E, Fourie PB, Peters RPH. | Antimicrob Agents Chemother | 10.1128/aac.00348-23 | 2023 | | |
| Local emergence and global evolution of Neisseria gonorrhoeae with high-level resistance to azithromycin. | Melendez JH, Edwards VL, Muniz Tirado A, Hardick J, Mehta A, Aluvathingal J, D'Mello A, Gaydos CA, Manabe YC, Tettelin H. | Antimicrob Agents Chemother | 10.1128/aac.00927-24 | 2024 | | |
| Emergence of Neisseria gonorrhoeae Clone with Reduced Susceptibility to Sitafloxacin in China: An In Vitro and Genomic Study. | Ye M, Yao L, Lu X, Ding F, Zou D, Tian T, Lin Y, Ning Z, Jiang J, Zhou P. | Antibiotics (Basel) | 10.3390/antibiotics13050468 | 2024 | | |
| In vitro Susceptibility to beta-Lactam Antibiotics and Viability of Neisseria gonorrhoeae Strains Producing Plasmid-Mediated Broad- and Extended-Spectrum beta-Lactamases. | Kandinov I, Gryadunov D, Vinokurova A, Antonova O, Kubanov A, Solomka V, Shagabieva J, Deryabin D, Shaskolskiy B. | Front Microbiol | 10.3389/fmicb.2022.896607 | 2022 | | |
| Enzymology | Evaluating the efficacy of different antibiotics against Neisseria gonorrhoeae: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation. | Zhong J, Le W, Li X, Su X. | BMC Infect Dis | 10.1186/s12879-023-08938-x | 2024 | |
| Neisseria gonorrhoeae antimicrobial resistance patterns and associated risk factors in women of childbearing potential in northwestern Ethiopia. | Demissie E, Amare A, Birhanu M, Gizachew M. | BMC Womens Health | 10.1186/s12905-024-02898-3 | 2024 | | |
| Antimicrobial resistance and molecular characteristics of Neisseria gonorrhoea isolates in Ghana. | Musah HS, Addy F, Dufailu OA. | Access Microbiol | 10.1099/acmi.0.000689.v3 | 2024 | | |
| Current alternative therapies for treating drug-resistant Neisseria gonorrhoeae causing ophthalmia neonatorum. | Belagal P. | Future Microbiol | 10.2217/fmb-2023-0251 | 2024 | | |
| Exploiting beta-Lactams-Induced Lysis and DNA Fragmentation for Rapid Molecular Antimicrobial Susceptibility Testing of Neisseria Gonorrhoeae via Dual-Digital PCR. | Hu J, Chen L, Zhang P, Chen FE, Li H, Hsieh K, Li S, Melendez JH, Wang TH. | Adv Sci (Weinh) | 10.1002/advs.202405272 | 2024 | | |
| Molecular epidemiological and antimicrobial-resistant mechanisms analysis of prolonged Neisseria gonorrhoeae collection between 1971 and 2005 in Japan. | Kagawa N, Aoki K, Komori K, Ishii Y, Shimuta K, Ohnishi M, Tateda K. | JAC Antimicrob Resist | 10.1093/jacamr/dlae040 | 2024 | | |
| Stable isotope labeling as a promising tool for rapid drug susceptibility testing in Neisseria gonorrhoeae. | Dadwal R, Paul S, Gupta P, Yadav R, Sood S, Ghosh AK, Shivaprakash MR, Gainder S, Sethi S. | Braz J Microbiol | 10.1007/s42770-023-00996-2 | 2023 | | |
| Pathogenicity | Exploring Candesartan, an angiotensin II receptor antagonist, as a novel inhibitor of NLRP3 inflammasome: alleviating inflammation in Neisseria gonorrhoeae infection. | Lin WY, Tsui JL, Chiu HW, Wong WT, Wu CH, Hsu HT, Ho CL, Yeh SP, Rao YK, Chen A, Wang CC, Hsu CH, Chernikov OV, Hua KF, Li LH. | BMC Infect Dis | 10.1186/s12879-024-10208-3 | 2024 | |
| Maximizing the Neisseria gonorrhoeae confirmatory rate and the genotypic detection of ciprofloxacin resistance for samples screened with cobas CT/NG. | Pryce TM, Foti OR, Haygarth EJ, Whiley DM. | J Clin Microbiol | 10.1128/jcm.01039-23 | 2024 | | |
| Visible colorimetric growth indicators of Neisseria gonorrhoeae for low-cost diagnostic applications. | Oeschger TM, Erickson DC. | PLoS One | 10.1371/journal.pone.0252961 | 2021 | | |
| Revolutionizing chronic endometritis diagnosis: real-time polymerase chain reaction unveils microbial pathogens in Indian women with abnormal bleeding and reproductive challenges. | Nandagopal M, Rajan N R, Padhiar C, Abhaya M, Bansal U, Ghambir P. | AJOG Glob Rep | 10.1016/j.xagr.2024.100377 | 2024 | | |
| Peptide barcode of multidrug-resistant strains of Neisseria gonorrhoeae isolated from patients in Thailand. | Roytrakul S, Sangprasert P, Jaresitthikunchai J, Phaonakrop N, Arpornsuwan T. | PLoS One | 10.1371/journal.pone.0289308 | 2023 | | |
| First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017-2020. | Al-Maslamani M, Elmagboul EBI, Puthiyottil A, Chemaitelly H, Varghese MK, Al Romaihi HE, Al-Thani MH, Al Khal A, Unemo M, Abu-Raddad LJ. | PLoS One | 10.1371/journal.pone.0264737 | 2022 | | |
| Neisseria gonorrhoeae antimicrobial susceptibility trends in Bangkok, Thailand, 2015-21: Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP). | Kittiyaowamarn R, Girdthep N, Cherdtrakulkiat T, Sangprasert P, Tongtoyai J, Weston E, Borisov A, Dunne EF, Chinhiran K, Woodring J, Ngarmjiratam N, Masciotra S, Frankson R, Sirivongrangson P, Unemo M, Wi T. | JAC Antimicrob Resist | 10.1093/jacamr/dlad139 | 2023 | | |
| Genetics | Genomic Diversity and Chromosomal Rearrangements in Neisseria gonorrhoeae and Neisseria meningitidis. | Shaskolskiy B, Kravtsov D, Kandinov I, Dementieva E, Gryadunov D. | Int J Mol Sci | 10.3390/ijms232415644 | 2022 | |
| Inhibitory Activity of Antibacterial Mouthwashes and Antiseptic Substances against Neisseria gonorrhoeae. | Williams E, Zhang B, Chow EPF, Chea S, Phillips TR, Maddaford K, Krysiak M, Nong Y, Stefanatos H, Pasricha S, Fairley CK, Wiliamson DA. | Antimicrob Agents Chemother | 10.1128/aac.00042-22 | 2022 | | |
| Honokiol Exhibits Anti-NLRP3 Inflammasome and Antimicrobial Properties in Neisseria gonorrhoeae-Infected Macrophages. | Hua KF, Hsu HT, Huang MS, Chiu HW, Wong WT, Peng CH, Lin YB, Chen A, Wang CC, Hsu CH, Wu CH, Lin WY, Ho CL, Li LH. | J Inflamm Res | 10.2147/jir.s454221 | 2024 | | |
| An extraction-free and one-pot two-temperature CRISPR/Cas12b system for visual detection of Group B Streptococcus by integrating with RPA. | Zhao C, Li G, Shen C, Xie Y, Chen Y, Ying X, Chen Y, Zhang C. | J Clin Microbiol | 10.1128/jcm.00819-25 | 2025 | | |
| Genetics | Use of genome sequencing to resolve differences in gradient diffusion and agar dilution antimicrobial susceptibility testing performance of Neisseria gonorrhoeae isolates in Alberta, Canada. | Ma A, Ferrato C, Martin I, Smyczek P, Gratrix J, Dingle TC. | J Clin Microbiol | 10.1128/jcm.00606-23 | 2023 | |
| Genetics | Dissemination of Neisseria gonorrhoeae with decreased susceptibility to extended-spectrum cephalosporins in Southern China, 2021: a genome-wide surveillance from 20 cities. | Liao Y, Xie Q, Li X, Yin X, Wu X, Liu M, Pan Y, Zeng L, Yang J, Feng Z, Qin X, Zheng H. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-023-00587-x | 2023 | |
| Natural-Product-Directed Catalytic Stereoselective Synthesis of Functionalized Fused Borane Cluster-Oxazoles for the Discovery of Bactericidal Agents. | Varkhedkar R, Yang F, Dontha R, Zhang J, Liu J, Spingler B, van der Veen S, Duttwyler S. | ACS Cent Sci | 10.1021/acscentsci.1c01132 | 2022 | | |
| Testing of In Vitro Susceptibility of Neisseria gonorrhoeae to Azithromycin: Comparison of Disk Diffusion and Reference Agar Dilution Methods. | Gianecini R, Irazu L, Rodriguez M, Cristaldo P, Oviedo C, Turco M, Rodrigo V, Canigia LF, Schneider A, Guelfand L, Scocozza L, GASSP-AR Working Group, Galarza P. | J Clin Microbiol | 10.1128/jcm.01398-20 | 2020 | | |
| Screening of Antimicrobial Properties and Bioactive Compounds of Pleurotus Ostreatus Extracts against Staphylococcus Aureus, Escherichia coli, and Neisseria Gonorrhoeae. | Yakobi SH, Mkhize S, Pooe OJ. | Biochem Res Int | 10.1155/2023/1777039 | 2023 | | |
| Impact of Alternative Growth Supplements on Antimicrobial Susceptibility Testing of Neisseria gonorrhoeae. | Zhou Q, Xu W, Xia D, Zhu X, Han Y, Chen K, Yin Y. | Infect Drug Resist | 10.2147/idr.s381361 | 2022 | | |
| Pathogenicity | In Vitro Efficacy of Gentamicin Alone and in Combination with Ceftriaxone, Ertapenem, and Azithromycin against Multidrug-Resistant Neisseria gonorrhoeae. | Li X, Le W, Lou X, Wang B, Genco CA, Rice PA, Su X. | Microbiol Spectr | 10.1128/spectrum.00181-21 | 2021 | |
| Molecular Characteristics and Gonococcal Genetic Island Carrying Status of Thirty-Seven Neisseria gonorrhoeae Isolates in Eastern China. | Zhang D, Hu M, Chi S, Chen H, Lin C, Yu F, Zheng Z. | Infect Drug Resist | 10.2147/idr.s385079 | 2022 | | |
| 1,3-Dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Expanding Structural Diversity and the Antibacterial Spectrum. | Lu Y, Mann CA, Nolan S, Collins JA, Parker E, Papa J, Vibhute S, Jahanbakhsh S, Thwaites M, Hufnagel D, Hazbon MH, Moreno J, Stedman TT, Wittum T, Wozniak DJ, Osheroff N, Yalowich JC, Mitton-Fry MJ. | ACS Med Chem Lett | 10.1021/acsmedchemlett.2c00111 | 2022 | | |
| Mycoplasma genitalium and sexually transmitted infections: evidences and figures in a tertiary hospital. | Martin-Saco G, Tristancho A, Arias A, Ferrer I, Milagro A, Garcia-Lechuz JM. | Rev Esp Quimioter | 10.37201/req/091.2021 | 2022 | | |
| Enzymology | Relationship between Gepotidacin Exposure and Prevention of On-Therapy Resistance Amplification in a Neisseria gonorrhoeae Hollow-Fiber In Vitro Infection Model. | VanScoy BD, Scangarella-Oman NE, Fikes S, Min S, Huang J, Ingraham K, Bhavnani SM, Conde H, Ambrose PG. | Antimicrob Agents Chemother | 10.1128/aac.00521-20 | 2020 | |
| Assessment of Antibiotic Resistance and Efflux Pump Gene Expression in Neisseria Gonorrhoeae Isolates from South Africa by Quantitative Real-Time PCR and Regression Analysis. | Mitchev N, Singh R, Ramsuran V, Ismail A, Allam M, Kwenda S, Mnyameni F, Garrett N, Swe Swe-Han K, Niehaus AJ, Mlisana KP. | Int J Microbiol | 10.1155/2022/7318325 | 2022 | | |
| Pathogenicity | Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017-2019. | Adamson PC, Van Le H, Le HHL, Le GM, Nguyen TV, Klausner JD. | BMC Infect Dis | 10.1186/s12879-020-05532-3 | 2020 | |
| Susceptibility Trends of Zoliflodacin against Multidrug-Resistant Neisseria gonorrhoeae Clinical Isolates in Nanjing, China, 2014 to 2018. | Le W, Su X, Lou X, Li X, Gong X, Wang B, Genco CA, Mueller JP, Rice PA. | Antimicrob Agents Chemother | 10.1128/aac.00863-20 | 2021 | | |
| Synthesis of Novel Triazine-Based Chalcones and 8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepines as Potential Leads in the Search of Anticancer, Antibacterial and Antifungal Agents. | Moreno LM, Quiroga J, Abonia R, Crespo MDP, Aranaga C, Martinez-Martinez L, Sortino M, Barreto M, Burbano ME, Insuasty B. | Int J Mol Sci | 10.3390/ijms25073623 | 2024 | | |
| Metabolism | Identification and Characterization of the Neisseria gonorrhoeae MscS-Like Mechanosensitive Channel. | Wang Z, Wang X, Lu P, Ni C, Li Y, van der Veen S. | Infect Immun | 10.1128/iai.00090-18 | 2018 | |
| Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of Neisseria gonorrhoeae clinical isolates from Thailand. | Nokchan N, Wongsurawat T, Jenjaroenpun P, Nitayanon P, Tribuddharat C. | PLoS One | 10.1371/journal.pone.0271657 | 2022 | | |
| Pathogenicity | Emergence of Neisseria gonorrhoeae Strains Harboring a Novel Combination of Azithromycin-Attenuating Mutations. | Pham CD, Sharpe S, Schlanger K, St Cyr S, Holderman J, Steece R, Soge OO, Masinde G, Arno J, Schmerer M, Kersh EN, SURRG Working Group. | Antimicrob Agents Chemother | 10.1128/aac.02313-18 | 2019 | |
| Overview of changes in the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: M100 32nd and 33rd editions. | Schuetz AN, Ferrell A, Hindler JA, Humphries R, Bobenchik AM. | J Clin Microbiol | 10.1128/jcm.01623-23 | 2025 | | |
| Pathogenicity | Antimicrobial susceptibility testing of Neisseria gonorrhoeae using a phenotypic-molecular assay and lyophilized antimicrobials. | Melendez JH, Chen FE, Wang TH. | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2021.115590 | 2022 | |
| Pathogenicity | Variability in Azithromycin Susceptibility Results for Neisseria gonorrhoeae Obtained Using Gradient MIC Strip and Agar Dilution Techniques. | McAuliffe GN, Smith M, Cooper G, Forster RF, Roberts SA. | J Clin Microbiol | 10.1128/jcm.01353-19 | 2019 | |
| Repositioning of 8-hydroxyquinoline derivatives as a new promising candidate for combating multidrug resistant Neisseria gonorrhoeae. | Lawung R, Cherdtrakulkiat R, Nabu S, Prachayasittikul S, Isarankura-Na-Ayudhya C, Prachayasittikul V. | EXCLI J | 10.17179/excli2018-1602 | 2018 | | |
| Analytical Evaluation of the Abbott RealTime CT/NG Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Rectal and Pharyngeal Swabs. | Adamson PC, Pandori MW, Doernberg SB, Komarow L, Sund Z, Tran TTT, Jensen D, Tsalik EL, Deal CD, Chambers HF, Fowler VG, Evans SR, Patel R, Klausner JD, Antibacterial Resistance Leadership Group. | J Mol Diagn | 10.1016/j.jmoldx.2020.03.004 | 2020 | | |
| A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant Neisseria gonorrhoeae and Other High-Threat Pathogens. | Park S, Russo R, Westfall L, Shrestha R, Zimmerman M, Dartois V, Kurepina N, Kreiswirth B, Singleton E, Li SG, Mittal N, Ahn YM, Bilotta J, Connolly KL, Jerse AE, Freundlich JS, Perlin DS. | Antimicrob Agents Chemother | 10.1128/aac.00414-22 | 2022 | | |
| Pathogenicity | Aminomethyl Spectinomycins as Therapeutics for Drug-Resistant Gonorrhea and Chlamydia Coinfections. | Butler MM, Waidyarachchi SL, Connolly KL, Jerse AE, Chai W, Lee RE, Kohlhoff SA, Shinabarger DL, Bowlin TL. | Antimicrob Agents Chemother | 10.1128/aac.00325-18 | 2018 | |
| Pathogenicity | In Vitro Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae. | Farrell DJ, Sader HS, Rhomberg PR, Scangarella-Oman NE, Flamm RK. | Antimicrob Agents Chemother | 10.1128/aac.02047-16 | 2017 | |
| Prevalence and Antimicrobial Susceptibility Patterns of Neisseria gonorrhoeae among Suspected Patients Attending Private Clinics in Jimma, Ethiopia. | Sahile A, Teshager L, Fekadie M, Gashaw M. | Int J Microbiol | 10.1155/2020/7672024 | 2020 | | |
| Enzymology | Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018. | Golparian D, Rose L, Lynam A, Mohamed A, Bercot B, Ohnishi M, Crowley B, Unemo M. | Euro Surveill | 10.2807/1560-7917.es.2018.23.47.1800617 | 2018 | |
| National surveillance of Neisseria gonorrhoeae antimicrobial susceptibility and epidemiological data of gonorrhoea patients across Brazil, 2018-20. | Machado HM, Martins JM, Schorner MA, Gaspar PC, Bigolin A, Ramos MC, Ferreira WA, Pereira GFM, Miranda AE, Unemo M, Bazzo ML, Brazilian-GASP Network . | JAC Antimicrob Resist | 10.1093/jacamr/dlac076 | 2022 | | |
| Antimicrobial Susceptibility of Urogenital and Extragenital Neisseria gonorrhoeae Isolates Among Men Who Have Sex With Men: Strengthening the US Response to Resistant Gonorrhea and Enhanced Gonococcal Isolate Surveillance Project, 2018 to 2019. | Quilter LAS, St Cyr SB, Hong J, Asbel L, Bautista I, Carter B, Casimir Y, Denny M, Ervin M, Gomez R, Harvey A, Holderman JL, Johnson K, Kohn RP, Learner ER, Mauk K, Menza T, Mettenbrink C, Nettleton WD, Nicosia KR, Pham CD, Ried C, Schlanger K, Schneider A, Soge OO, Tabidze I, Taylor SN, Tilghman W, Toler C, Weinstock H, Torrone EA. | Sex Transm Dis | 10.1097/olq.0000000000001548 | 2021 | | |
| Antimicrobial Resistance Mechanisms, Multilocus Sequence Typing, and NG-STAR Sequence Types of Diverse Neisseria gonorrhoeae Isolates in KwaZulu-Natal, South Africa. | Mitchev N, Singh R, Allam M, Kwenda S, Ismail A, Garrett N, Ramsuran V, Niehaus AJ, Mlisana KP. | Antimicrob Agents Chemother | 10.1128/aac.00759-21 | 2021 | | |
| Pathogenicity | Multidrug-resistant Neisseria gonorrhoeae infection in heterosexual men with reduced susceptibility to ceftriaxone, first report in Thailand. | Kueakulpattana N, Wannigama DL, Luk-In S, Hongsing P, Hurst C, Badavath VN, Jenjaroenpun P, Wongsurawat T, Teeratakulpisan N, Kerr SJ, Abe S, Phattharapornjaroen P, Shein AMS, Saethang T, Chantaravisoot N, Amarasiri M, Higgins PG, Chatsuwan T. | Sci Rep | 10.1038/s41598-021-00675-y | 2021 | |
| PrintrLab incubator: A portable and low-cost CO2 incubator based on an open-source 3D printer architecture. | Arumugam A, Markham C, Aykar SS, Van Der Pol B, Dixon P, Wu M, Wong S. | PLoS One | 10.1371/journal.pone.0251812 | 2021 | | |
| Trends in Antimicrobial Resistance Patterns in Neisseria Gonorrhoeae in Australia and New Zealand: A Meta-analysis and Systematic Review. | Fletcher-Lartey S, Dronavalli M, Alexander K, Ghosh S, Boonwaat L, Thomas J, Robinson A, Patel Z, Forssman B, Pal N. | Antibiotics (Basel) | 10.3390/antibiotics8040191 | 2019 | | |
| NG-STAR genotypes are associated with MDR in Neisseria gonorrhoeae isolates collected in 2017 in Shanghai. | Yang Y, Yang Y, Martin I, Dong Y, Diao N, Wang Y, Demczuk W, Gu W. | J Antimicrob Chemother | 10.1093/jac/dkz471 | 2020 | | |
| Pathogenicity | In vitro activity of EDTA and TOL-463 against Neisseria gonorrhoeae. | Nash EE, Henning TC, Pham CD, Pettus K, Sharpe S, Kersh EN. | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2018.10.021 | 2019 | |
| Pathogenicity | Progesterone Suppresses Neisseria gonorrhoeae-Induced Inflammation Through Inhibition of NLRP3 Inflammasome Pathway in THP-1 Cells and Murine Models. | Zhang S, Zhang Y, Gan L, Wei F, Chai B, A Aljaafreh AAH, Liu X, Duan X, Jiang J, Wang X, He M, Huang X, Cai H, Chen T, Chen H. | Front Microbiol | 10.3389/fmicb.2021.570093 | 2021 | |
| Pathogenicity | Antimicrobial susceptibility of Neisseria gonorrhoeae in Barcelona during a five-year period, 2013 to 2017. | Salmeron P, Vinado B, El Ouazzani R, Hernandez M, Barbera MJ, Alberny M, Jane M, Larrosa N, Pumarola T, Hoyos-Mallecot Y, Serra-Pladevall J. | Euro Surveill | 10.2807/1560-7917.es.2020.25.42.1900576 | 2020 | |
| Enzymology | Identification of Neisseria gonorrhoeae by the Bruker Biotyper Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry System Is Improved by a Database Extension. | Schweitzer VA, van Dam AP, Hananta IP, Schuurman R, Kusters JG, Rentenaar RJ. | J Clin Microbiol | 10.1128/jcm.00016-16 | 2016 | |
| Combination of compound screening with an animal model identifies pentamidine to prevent Chlamydia trachomatis infection. | Knapp K, Klasinc R, Koren A, Siller M, Dingelmaier-Hovorka R, Drach M, Sanchez J, Chromy D, Kranawetter M, Grimm C, Bergthaler A, Kubicek S, Stockinger H, Stary G. | Cell Rep Med | 10.1016/j.xcrm.2024.101643 | 2024 | | |
| Pathogenicity | Direct-qPCR Assay for Coupled Identification and Antimicrobial Susceptibility Testing of Neisseria gonorrhoeae. | Chen L, Shin DJ, Zheng S, Melendez JH, Gaydos CA, Wang TH. | ACS Infect Dis | 10.1021/acsinfecdis.8b00104 | 2018 | |
| Comparative proteomics analysis of Neisseria gonorrhoeae strains in response to extended-spectrum cephalosporins. | Nabu S, Lawung R, Isarankura-Na-Ayudhya P, Roytrakul S, Dolprasit S, Sengyee S, Isarankura-Na-Ayudhya C, Prachayasittikul V. | EXCLI J | 10.17179/excli2017-832 | 2017 | | |
| Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their Biofilms. | Padalino G, Duggan K, Mur LAJ, Maillard JY, Brancale A, Hoffmann KF. | Microbiologyopen | 10.1002/mbo3.70011 | 2024 | | |
| Gradient diffusion susceptibility testing for Neisseria gonorrhoeae: an accurate alternative to agar dilution in high-MIC strains? | Desjardins M, Lefebvre B, Lavallee C, Labbe AC, Mauffrey F, Martin I, Longtin J, Fortin C. | Access Microbiol | 10.1099/acmi.0.000116 | 2020 | | |
| The ethnomedicine, phytochemistry, and pharmacological properties of the genus Bersama: current review and future perspectives. | Nigussie G, Ashenef S, Meresa A. | Front Pharmacol | 10.3389/fphar.2024.1366427 | 2024 | | |
| Antibacterial Activity of Propolis Extracts from the Central Region of Romania against Neisseria gonorrhoeae. | Vica ML, Glevitzky I, Glevitzky M, Siserman CV, Matei HV, Teodoru CA. | Antibiotics (Basel) | 10.3390/antibiotics10060689 | 2021 | | |
| Genetics | Genomic Characterization of Emerging Bacterial Uropathogen Neisseria meningitidis, Which Was Misidentified as Neisseria gonorrhoeae by Nucleic Acid Amplification Testing. | Sukhum KV, Jean S, Wallace M, Anderson N, Burnham CA, Dantas G. | J Clin Microbiol | 10.1128/jcm.01699-20 | 2021 | |
| A portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibility. | Trick AY, Melendez JH, Chen FE, Chen L, Onzia A, Zawedde A, Nakku-Joloba E, Kyambadde P, Mande E, Matovu J, Atuheirwe M, Kwizera R, Gilliams EA, Hsieh YH, Gaydos CA, Manabe YC, Hamill MM, Wang TH. | Sci Transl Med | 10.1126/scitranslmed.abf6356 | 2021 | | |
| Substitutions in SurA and BamA Lead to Reduced Susceptibility to Broad Range Antibiotics in Gonococci. | Bodoev I, Malakhova M, Bespyatykh J, Bespiatykh D, Arapidi G, Pobeguts O, Zgoda V, Shitikov E, Ilina E. | Genes (Basel) | 10.3390/genes12091312 | 2021 | | |
| Phylogeny | Confirmation of the Need for Reclassification of Neisseria mucosa and Neisseria sicca Using Average Nucleotide Identity Blast and Phylogenetic Analysis of Whole-Genome Sequencing: Hinted by Clinical Misclassification of a Neisseria mucosa Strain. | Jin Y, Xu H, Yao Q, Gu B, Wang Z, Wang T, Yu X, Lu Y, Zheng B, Zhang Y. | Front Microbiol | 10.3389/fmicb.2021.780183 | 2021 | |
| Rationale for a Neisseria gonorrhoeae Susceptible-only Interpretive Breakpoint for Azithromycin. | Kersh EN, Allen V, Ransom E, Schmerer M, Cyr S, Workowski K, Weinstock H, Patel J, Ferraro MJ. | Clin Infect Dis | 10.1093/cid/ciz292 | 2020 | | |
| Case Report of Urethritis in a Male Patient Infected with Two Different Isolates of Multiple Drug-Resistant Neisseria gonorrhoeae. | Al-Madboly L, Gheida S. | Front Med (Lausanne) | 10.3389/fmed.2017.00194 | 2017 | | |
| Pathogenicity | Emergence and Spread of Neisseria gonorrhoeae Strains with High-Level Resistance to Azithromycin in Taiwan from 2001 to 2018. | Liu YH, Wang YH, Liao CH, Hsueh PR. | Antimicrob Agents Chemother | 10.1128/aac.00773-19 | 2019 | |
| Pathogenicity | Temporal evolution of antimicrobial resistance among Neisseria gonorrhoeae clinical isolates in the most populated South American Metropolitan Region. | Martins RA, Cassu-Corsi D, Nodari CS, Cayo R, Natsumeda L, Streling AP, Doi AM, da Silva RJC, Bocalon RAL, Gales AC, Pignatari ACC. | Mem Inst Oswaldo Cruz | 10.1590/0074-02760190079 | 2019 | |
| Pathogenicity | Antimicrobial susceptibility of Neisseria gonorrhoeae isolates in Vientiane, Lao PDR. | Phouangsouvanh S, Mayxay M, Keoluangkhot V, Vongsouvath M, Davong V, Dance DAB. | J Glob Antimicrob Resist | 10.1016/j.jgar.2017.12.001 | 2018 | |
| Biosynthesis and Chemical Synthesis of Albomycin Nucleoside Antibiotics. | Wang M, Zhang Y, Lv L, Kong D, Niu G. | Antibiotics (Basel) | 10.3390/antibiotics11040438 | 2022 | | |
| Genotypic and Phenotypic Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae: a Cross-Sectional Study of Isolates Recovered from Routine Urine Cultures in a High-Incidence Setting. | Bailey AL, Potter RF, Wallace MA, Johnson C, Dantas G, Burnham CA. | mSphere | 10.1128/msphere.00373-19 | 2019 | | |
| Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates in Baltimore, Maryland, 2016: The Importance of Sentinel Surveillance in the Era of Multi-Drug-Resistant Gonorrhea. | Melendez JH, Hardick J, Barnes M, Page KR, Gaydos CA. | Antibiotics (Basel) | 10.3390/antibiotics7030077 | 2018 | | |
| Pathogenicity | In Vitro Activity of Lefamulin against Sexually Transmitted Bacterial Pathogens. | Paukner S, Gruss A, Jensen JS. | Antimicrob Agents Chemother | 10.1128/aac.02380-17 | 2018 | |
| Pathogenicity | Evaluation of apramycin against spectinomycin-resistant and -susceptible strains of Neisseria gonorrhoeae. | Riedel S, Vijayakumar D, Berg G, Kang AD, Smith KP, Kirby JE. | J Antimicrob Chemother | 10.1093/jac/dkz012 | 2019 | |
| Pathogenicity | Antimicrobial resistance (AMR) and molecular characterization of Neisseria gonorrhoeae in Ghana, 2012-2015. | Attram N, Agbodzi B, Dela H, Behene E, Nyarko EO, Kyei NNA, Larbi JA, Lawson BWL, Addo KK, Newman MJ, Duplessis CA, Adams N, Unemo M, Letizia AG. | PLoS One | 10.1371/journal.pone.0223598 | 2019 | |
| Shanghai Neisseria gonorrhoeae Isolates Exhibit Resistance to Extended-Spectrum Cephalosporins and Clonal Distribution. | Dong Y, Yang Y, Wang Y, Martin I, Demczuk W, Gu W. | Front Microbiol | 10.3389/fmicb.2020.580399 | 2020 | | |
| Pathogenicity | External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany. | Selb R, Jansen K, Eckardt M, Tamminga T, Dudareva S, Gassowski M, Graeber I, Guhl E, Heuer D, Buder S, GORENET EQA study group. | BMC Infect Dis | 10.1186/s12879-020-05234-w | 2020 | |
| Evidence for Clonally Associated Increasing Rates of Azithromycin Resistant Neisseria gonorrhoeae in Rio de Janeiro, Brazil. | Barros Dos Santos KT, Skaf LB, Justo-da-Silva LH, Medeiros RC, Francisco Junior RDS, Canine MCA, Fracalanzza SEL, Bonelli RR. | Biomed Res Int | 10.1155/2019/3180580 | 2019 | | |
| Pathogenicity | Accuracy and reproducibility of the Etest to detect drug-resistant Neisseria gonorrhoeae to contemporary treatment. | Papp JR, Rowlinson MC, O'Connor NP, Wholehan J, Razeq JH, Glennen A, Ware D, Iwen PC, Lee LV, Hagan C. | J Med Microbiol | 10.1099/jmm.0.000651 | 2018 | |
| Antimicrobial Resistance And Molecular Characteristics Among Neisseria gonorrhoeae Clinical Isolates In A Chinese Tertiary Hospital. | Zheng Z, Liu L, Shen X, Yu J, Chen L, Zhan L, Chen H, Lin C, Jiang Y, Xia H, Wang L, Yu F. | Infect Drug Resist | 10.2147/idr.s221109 | 2019 | | |
| Genetics | Expanding U.S. Laboratory Capacity for Neisseria gonorrhoeae Antimicrobial Susceptibility Testing and Whole-Genome Sequencing through the CDC's Antibiotic Resistance Laboratory Network. | Kersh EN, Pham CD, Papp JR, Myers R, Steece R, Kubin G, Gautom R, Nash EE, Sharpe S, Gernert KM, Schmerer M, Raphael BH, Henning T, Gaynor AM, Soge O, Schlanger K, Kirkcaldy RD, St Cyr SB, Torrone EA, Bernstein K, Weinstock H. | J Clin Microbiol | 10.1128/jcm.01461-19 | 2020 | |
| Phylogeny | Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report. | Workneh M, Hamill MM, Kakooza F, Mande E, Wagner J, Mbabazi O, Mugasha R, Kajumbula H, Walwema R, Zenilman J, Musinguzi P, Kyambadde P, Lamorde M, Manabe YC. | JMIR Public Health Surveill | 10.2196/17009 | 2020 | |
| Pathogenicity | trans-Translation inhibitors bind to a novel site on the ribosome and clear Neisseria gonorrhoeae in vivo. | Aron ZD, Mehrani A, Hoffer ED, Connolly KL, Srinivas P, Torhan MC, Alumasa JN, Cabrera M, Hosangadi D, Barbor JS, Cardinale SC, Kwasny SM, Morin LR, Butler MM, Opperman TJ, Bowlin TL, Jerse A, Stagg SM, Dunham CM, Keiler KC. | Nat Commun | 10.1038/s41467-021-22012-7 | 2021 | |
| Pathogenicity | Gentamicin Susceptibility among a Sample of Multidrug-Resistant Neisseria gonorrhoeae Isolates in India. | Bala M, Singh V, Bhargava A, Kakran M, Joshi NC, Bhatnagar R. | Antimicrob Agents Chemother | 10.1128/aac.01907-16 | 2016 | |
| A broad-spectrum synthetic antibiotic that does not evoke bacterial resistance. | Heithoff DM, Mahan SP, Barnes V L, Leyn SA, George CX, Zlamal JE, Limwongyut J, Bazan GC, Fried JC, Fitzgibbons LN, House JK, Samuel CE, Osterman AL, Low DA, Mahan MJ. | EBioMedicine | 10.1016/j.ebiom.2023.104461 | 2023 | | |
| Enzymology | Nucleic acid amplification tests (NAATs) for gonorrhoea diagnosis in women: experience of a tertiary care hospital in north India. | Sood S, Verma R, Mir SS, Agarwal M, Singh N, Kar HK, Sharma VK. | Indian J Med Res | 2014 | | |
| Pathogenicity | In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era. | Singh V, Bala M, Bhargava A, Kakran M, Bhatnagar R. | PLoS One | 10.1371/journal.pone.0193678 | 2018 | |
| Pathogenicity | Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae. | Alm RA, Lahiri SD, Kutschke A, Otterson LG, McLaughlin RE, Whiteaker JD, Lewis LA, Su X, Huband MD, Gardner H, Mueller JP. | Antimicrob Agents Chemother | 10.1128/aac.04456-14 | 2015 | |
| Pathogenicity | Antimicrobial susceptibility testing of Neisseria gonorrhoeae isolates in Pakistan by Etest compared to Calibrated Dichotomous Sensitivity and Clinical Laboratory Standards Institute disc diffusion techniques. | Mal PB, Jabeen K, Farooqi J, Unemo M, Khan E. | BMC Microbiol | 10.1186/s12866-016-0707-6 | 2016 | |
| Pathogenicity | Susceptibility of endometrial isolates recovered from women with clinical pelvic inflammatory disease or histological endometritis to antimicrobial agents. | Petrina MAB, Cosentino LA, Wiesenfeld HC, Darville T, Hillier SL. | Anaerobe | 10.1016/j.anaerobe.2019.02.005 | 2019 | |
| Pathogenicity | In vitro growth of multidrug-resistant Neisseria gonorrhoeae isolates is inhibited by ETX0914, a novel spiropyrimidinetrione. | Papp JR, Lawrence K, Sharpe S, Mueller J, Kirkcaldy RD. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2016.05.018 | 2016 | |
| Enzymology | Mismatch Amplification Mutation Assay-Based Real-Time PCR for Rapid Detection of Neisseria gonorrhoeae and Antimicrobial Resistance Determinants in Clinical Specimens. | Dona V, Smid JH, Kasraian S, Egli-Gany D, Dost F, Imeri F, Unemo M, Low N, Endimiani A. | J Clin Microbiol | 10.1128/jcm.00365-18 | 2018 | |
| In Vitro and In Vivo Properties of CUO246, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor. | Blais J, Dean CR, Lapointe G, Leeds JA, Ma S, Morris L, Moser HE, Osborne CS, Prosen KR, Richie D, Skepper C, Thompson K, Vo J, Yue Q, Rivkin A. | Antimicrob Agents Chemother | 10.1128/aac.00921-22 | 2022 | | |
| Pathogenicity | Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914). | Su XH, Wang BX, Le WJ, Liu YR, Wan C, Li S, Alm RA, Mueller JP, Rice PA. | Antimicrob Agents Chemother | 10.1128/aac.01211-15 | 2016 | |
| Phylogeny | Genomic Epidemiology and Molecular Resistance Mechanisms of Azithromycin-Resistant Neisseria gonorrhoeae in Canada from 1997 to 2014. | Demczuk W, Martin I, Peterson S, Bharat A, Van Domselaar G, Graham M, Lefebvre B, Allen V, Hoang L, Tyrrell G, Horsman G, Wylie J, Haldane D, Archibald C, Wong T, Unemo M, Mulvey MR. | J Clin Microbiol | 10.1128/jcm.03195-15 | 2016 | |
| Pathogenicity | Identification of Novel Neisseria gonorrhoeae Lineages Harboring Resistance Plasmids in Coastal Kenya. | Cehovin A, Harrison OB, Lewis SB, Ward PN, Ngetsa C, Graham SM, Sanders EJ, Maiden MCJ, Tang CM. | J Infect Dis | 10.1093/infdis/jiy240 | 2018 | |
| The first year of the global Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) in Bangkok, Thailand, 2015-2016. | Sirivongrangson P, Girdthep N, Sukwicha W, Buasakul P, Tongtoyai J, Weston E, Papp J, Wi T, Cherdtrakulkiat T, Dunne EF, EGASP Thailand Workgroup. | PLoS One | 10.1371/journal.pone.0206419 | 2018 | | |
| Antibiotic Susceptibility Monitoring of Neisseria gonorrhoeae in Bacolod City, Philippines. | Araneta CMP, Juayang AC, Lim JPT, Quilop EMG, Casaysay NJG, Tamesis GML, Yude TMG, Romero SJE, Gayoba RC. | Trop Med Infect Dis | 10.3390/tropicalmed2030045 | 2017 | | |
| Pathogenicity | Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors. | D'Atanasio N, Capezzone de Joannon A, Di Sante L, Mangano G, Ombrato R, Vitiello M, Bartella C, Magaro G, Prati F, Milanese C, Vignaroli C, Di Giorgio FP, Tongiani S. | PLoS One | 10.1371/journal.pone.0228509 | 2020 | |
| Pathogenicity | Quality Assurance for Antimicrobial Susceptibility Testing of Neisseria gonorrhoeae in Canada, 2003 to 2012. | Sawatzky P, Liu G, Dillon JA, Allen V, Lefebvre B, Hoang L, Tyrrell G, Van Caeseele P, Levett P, Martin I. | J Clin Microbiol | 10.1128/jcm.02303-15 | 2015 | |
| Identification of TEM-135 beta-lactamase in Neisseria gonorrhoeae strains carrying African and Toronto plasmids in Argentina. | Gianecini R, Oviedo C, Littvik A, Mendez E, Piccoli L, Montibello S, Galarza P. | Antimicrob Agents Chemother | 10.1128/aac.03838-14 | 2015 | | |
| Pathogenicity | Increasing Resistance to Azithromycin in Neisseria gonorrhoeae in Eastern Chinese Cities: Resistance Mechanisms and Genetic Diversity among Isolates from Nanjing. | Wan C, Li Y, Le WJ, Liu YR, Li S, Wang BX, Rice PA, Su XH. | Antimicrob Agents Chemother | 10.1128/aac.02499-17 | 2018 | |
| Mechanistic Insight Into the Activation of the NLRP3 Inflammasome by Neisseria gonorrhoeae in Macrophages. | Li LH, Lin JS, Chiu HW, Lin WY, Ju TC, Chen FH, Chernikov OV, Liu ML, Chang JC, Hsu CH, Chen A, Ka SM, Gao HW, Hua KF. | Front Immunol | 10.3389/fimmu.2019.01815 | 2019 | | |
| Comparing the disk-diffusion and agar dilution tests for Neisseria gonorrhoeae antimicrobial susceptibility testing. | Liu H, Taylor TH, Pettus K, Johnson S, Papp JR, Trees D. | Antimicrob Resist Infect Control | 10.1186/s13756-016-0148-x | 2016 | | |
| Pathogenicity | Antimicrobial susceptibility profile of Gonococcal isolates obtained from men presenting with urethral discharge in Addis Ababa, Ethiopia: Implications for national syndromic treatment guideline. | Fentaw S, Abubeker R, Asamene N, Assefa M, Bekele Y, Tigabu E. | PLoS One | 10.1371/journal.pone.0233753 | 2020 | |
| Combretastatins D series and analogues: from isolation, synthetic challenges and biological activities. | de Lima Neto J, Menezes PH. | Beilstein J Org Chem | 10.3762/bjoc.19.31 | 2023 | | |
| Comparison of two disc diffusion methods with minimum inhibitory concentration for antimicrobial susceptibility testing of Neisseria gonorrhoeae isolates. | Khaki P, Sharma A, Bhalla P. | Ann Med Health Sci Res | 10.4103/2141-9248.133477 | 2014 | | |
| Emerging azithromycin-resistance among the Neisseria gonorrhoeae strains isolated in Hungary. | Brunner A, Nemes-Nikodem E, Jeney C, Szabo D, Marschalko M, Karpati S, Ostorhazi E. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-016-0166-9 | 2016 | | |
| Enzymology | Assessment of Etest as an alternative to agar dilution for antimicrobial susceptibility testing of Neisseria gonorrhoeae. | Liu H, Taylor TH, Pettus K, Trees D. | J Clin Microbiol | 10.1128/jcm.02131-13 | 2014 | |
| Pathogenicity | WGS to predict antibiotic MICs for Neisseria gonorrhoeae. | Eyre DW, De Silva D, Cole K, Peters J, Cole MJ, Grad YH, Demczuk W, Martin I, Mulvey MR, Crook DW, Walker AS, Peto TEA, Paul J. | J Antimicrob Chemother | 10.1093/jac/dkx067 | 2017 | |
| Pathogenicity | Increasing Incidence of High-Level Tetracycline-Resistant Neisseria gonorrhoeae due to Clonal Spread and Foreign Import. | Lee H, Kim H, Kim HJ, Suh YH, Yong D, Jeong SH, Lee K, Chong Y. | Yonsei Med J | 10.3349/ymj.2016.57.2.350 | 2016 | |
| Phylogeny | Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand. | Lee RS, Seemann T, Heffernan H, Kwong JC, Goncalves da Silva A, Carter GP, Woodhouse R, Dyet KH, Bulach DM, Stinear TP, Howden BP, Williamson DA. | J Antimicrob Chemother | 10.1093/jac/dkx405 | 2018 | |
| Phylogeny | Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance, a Novel Antimicrobial Resistance Multilocus Typing Scheme for Tracking Global Dissemination of N. gonorrhoeae Strains. | Demczuk W, Sidhu S, Unemo M, Whiley DM, Allen VG, Dillon JR, Cole M, Seah C, Trembizki E, Trees DL, Kersh EN, Abrams AJ, de Vries HJC, van Dam AP, Medina I, Bharat A, Mulvey MR, Van Domselaar G, Martin I. | J Clin Microbiol | 10.1128/jcm.00100-17 | 2017 | |
| The frequency of Neisseria gonorrhoeae endocervical infection among female carrier and changing trends of antimicrobial susceptibility patterns in Kashan, Iran. | Afrasiabi S, Moniri R, Samimi M, Mousavi SG. | Iran J Microbiol | 2014 | | ||
| Pathogenicity | Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance. | Buder S, Dudareva S, Jansen K, Loenenbach A, Nikisins S, Sailer A, Guhl E, Kohl PK, Bremer V, GORENET study group. | BMC Infect Dis | 10.1186/s12879-018-2944-9 | 2018 | |
| Pathogenicity | Effect of Variants of Penicillin-Binding Protein 2 on Cephalosporin and Carbapenem Susceptibilities in Neisseria gonorrhoeae. | Bharat A, Demczuk W, Martin I, Mulvey MR. | Antimicrob Agents Chemother | 10.1128/aac.05143-14 | 2015 | |
| Pathogenicity | Whole-genome phylogenomic heterogeneity of Neisseria gonorrhoeae isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013. | Demczuk W, Lynch T, Martin I, Van Domselaar G, Graham M, Bharat A, Allen V, Hoang L, Lefebvre B, Tyrrell G, Horsman G, Haldane D, Garceau R, Wylie J, Wong T, Mulvey MR. | J Clin Microbiol | 10.1128/jcm.02589-14 | 2015 | |
| Enzymology | Genital Chlamydia trachomatis Infection among Women of Reproductive Age Attending the Gynecology Clinic of Hawassa University Referral Hospital, Southern Ethiopia. | Tadesse E, Teshome M, Amsalu A, Shimelis T. | PLoS One | 10.1371/journal.pone.0168580 | 2016 | |
| Molecular epidemiology of drug-resistant Neisseria gonorrhoeae in Russia (Current Status, 2015). | Kubanov A, Vorobyev D, Chestkov A, Leinsoo A, Shaskolskiy B, Dementieva E, Solomka V, Plakhova X, Gryadunov D, Deryabin D. | BMC Infect Dis | 10.1186/s12879-016-1688-7 | 2016 | | |
| Genital infections and reproductive complications associated with Trichomonas vaginalis, Neisseria gonorrhoeae, and Streptococcus agalactiae in women of Qom, central Iran. | Nateghi Rostami M, Hossein Rashidi B, Habibi A, Nazari R, Dolati M. | Int J Reprod Biomed | 10.29252/ijrm.15.6.357 | 2017 | | |
| Pathogenicity | Azithromycin resistance and its mechanism in Neisseria gonorrhoeae strains in Hyogo, Japan. | Shigemura K, Osawa K, Miura M, Tanaka K, Arakawa S, Shirakawa T, Fujisawa M. | Antimicrob Agents Chemother | 10.1128/aac.04320-14 | 2015 | |
| Neisseria gonorrhoeae among suspects of sexually transmitted infection in Gambella hospital, Ethiopia: risk factors and drug resistance. | Ali S, Sewunet T, Sahlemariam Z, Kibru G. | BMC Res Notes | 10.1186/s13104-016-2247-4 | 2016 | | |
| Pathogenicity | Design and Synthesis of New 6-Nitro and 6-Amino-3,3a,4,5-Tetrahydro-2H-Benzo[g]indazole Derivatives: Antiproliferative and Antibacterial Activity. | Cuartas V, Crespo MDP, Priego EM, Persoons L, Daelemans D, Camarasa MJ, Insuasty B, Perez-Perez MJ. | Molecules | 10.3390/molecules24234236 | 2019 | |
| Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains from Shandong Province, China. | Zhao LH, Zhao SP. | Braz J Microbiol | 10.1590/s1517-83822013005000020 | 2013 | | |
| Enzymology | Emergence of fluoroquinolone resistance in Neisseria gonorrhoeae isolates from four clinics in three regions of Kenya. | Lagace-Wiens PR, Duncan S, Kimani J, Thiong'o A, Shafi J, McClelland S, Sanders EJ, Zhanel G, Muraguri N, Mehta SD. | Sex Transm Dis | 10.1097/olq.0b013e318248a85f | 2012 | |
| Direct Matrix-Assisted Laser Desorption-Ionisation (MALDI) Mass-Spectrometry Bacteria Profiling for Identifying and Characterizing Pathogens. | Ilina EN. | Acta Naturae | 10.32607/20758251-2009-1-1-115-120 | 2009 | | |
| Metabolism | Prevalence of bla TEM-220 gene in Penicillinase-producing Neisseria gonorrhoeae strains carrying Toronto/Rio plasmid in Argentina, 2002 - 2011. | Gianecini R, Oviedo C, Guantay C, Piccoli L, Stafforini G, Galarza P. | BMC Infect Dis | 10.1186/s12879-015-1294-0 | 2015 | |
| Total synthesis and antimicrobial evaluation of natural albomycins against clinical pathogens. | Lin Z, Xu X, Zhao S, Yang X, Guo J, Zhang Q, Jing C, Chen S, He Y. | Nat Commun | 10.1038/s41467-018-05821-1 | 2018 | | |
| In vitro Activity of Robenidine Analog NCL195 in Combination With Outer Membrane Permeabilizers Against Gram-Negative Bacterial Pathogens and Impact on Systemic Gram-Positive Bacterial Infection in Mice. | Pi H, Nguyen HT, Venter H, Boileau AR, Woolford L, Garg S, Page SW, Russell CC, Baker JR, McCluskey A, O'Donovan LA, Trott DJ, Ogunniyi AD. | Front Microbiol | 10.3389/fmicb.2020.01556 | 2020 | | |
| Enzymology | Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary. | Brunner A, Nemes-Nikodem E, Mihalik N, Marschalko M, Karpati S, Ostorhazi E. | BMC Infect Dis | 10.1186/1471-2334-14-433 | 2014 | |
| Antioxidant and antibacterial activity of Rhoeo spathacea (Swartz) Stearn leaves. | Tan JB, Lim YY, Lee SM. | J Food Sci Technol | 10.1007/s13197-013-1236-z | 2015 | | |
| Pathogenicity | In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae. | Barbee LA, Soge OO, Holmes KK, Golden MR. | J Antimicrob Chemother | 10.1093/jac/dkt540 | 2014 | |
| Azithromycin-resistant Neisseria gonorrhoeae isolates in Guangzhou, China (2009-2013): coevolution with decreased susceptibilities to ceftriaxone and genetic characteristics. | Liang JY, Cao WL, Li XD, Bi C, Yang RD, Liang YH, Li P, Ye XD, Chen XX, Zhang XB. | BMC Infect Dis | 10.1186/s12879-016-1469-3 | 2016 | | |
| Multiplex Real-Time PCR Assay with High-Resolution Melting Analysis for Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae. | Dona V, Kasraian S, Lupo A, Guilarte YN, Hauser C, Furrer H, Unemo M, Low N, Endimiani A. | J Clin Microbiol | 10.1128/jcm.03354-15 | 2016 | | |
| Pathogenicity | Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae. | Chu H, Slepenkin A, Elofsson M, Keyser P, de la Maza LM, Peterson EM. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2010.03.018 | 2010 | |
| Pathogenicity | In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria. | Ito A, Sato T, Ota M, Takemura M, Nishikawa T, Toba S, Kohira N, Miyagawa S, Ishibashi N, Matsumoto S, Nakamura R, Tsuji M, Yamano Y. | Antimicrob Agents Chemother | 10.1128/aac.01454-17 | 2018 | |
| Pathogenicity | Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States. | Goldstein E, Kirkcaldy RD, Reshef D, Berman S, Weinstock H, Sabeti P, Del Rio C, Hall G, Hook EW, Lipsitch M. | Emerg Infect Dis | 10.3201/eid1808.111202 | 2012 | |
| Pathogenicity | The antimicrobial potential of cannabidiol. | Blaskovich MAT, Kavanagh AM, Elliott AG, Zhang B, Ramu S, Amado M, Lowe GJ, Hinton AO, Pham DMT, Zuegg J, Beare N, Quach D, Sharp MD, Pogliano J, Rogers AP, Lyras D, Tan L, West NP, Crawford DW, Peterson ML, Callahan M, Thurn M. | Commun Biol | 10.1038/s42003-020-01530-y | 2021 | |
| Pathogenicity | Molecular Assay for Detection of Genetic Markers Associated with Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeae. | Peterson SW, Martin I, Demczuk W, Bharat A, Hoang L, Wylie J, Allen V, Lefebvre B, Tyrrell G, Horsman G, Haldane D, Garceau R, Wong T, Mulvey MR. | J Clin Microbiol | 10.1128/jcm.00493-15 | 2015 | |
| Pathogenicity | Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea. | Lee H, Unemo M, Kim HJ, Seo Y, Lee K, Chong Y. | J Antimicrob Chemother | 10.1093/jac/dkv146 | 2015 | |
| Pathogenicity | Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections. | Bruhn DF, Waidyarachchi SL, Madhura DB, Shcherbakov D, Zheng Z, Liu J, Abdelrahman YM, Singh AP, Duscha S, Rathi C, Lee RB, Belland RJ, Meibohm B, Rosch JW, Bottger EC, Lee RE. | Sci Transl Med | 10.1126/scitranslmed.3010572 | 2015 | |
| Pathogenicity | Killing of Neisseria gonorrhoeae, Streptococcus agalactiae (group B streptococcus), Haemophilus ducreyi, and vaginal Lactobacillus by 3-O-octyl-sn-glycerol. | Moncla BJ, Pryke K, Isaacs CE. | Antimicrob Agents Chemother | 10.1128/aac.01023-07 | 2008 | |
| Proteomics of Neisseria gonorrhoeae: the treasure hunt for countermeasures against an old disease. | Baarda BI, Sikora AE. | Front Microbiol | 10.3389/fmicb.2015.01190 | 2015 | | |
| Enzymology | Direct bacterial profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for identification of pathogenic Neisseria. | Ilina EN, Borovskaya AD, Malakhova MM, Vereshchagin VA, Kubanova AA, Kruglov AN, Svistunova TS, Gazarian AO, Maier T, Kostrzewa M, Govorun VM. | J Mol Diagn | 10.2353/jmoldx.2009.080079 | 2009 | |
| Proteome | Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development. | Jacques S, van der Sloot AM, C Huard C, Coulombe-Huntington J, Tsao S, Tollis S, Bertomeu T, Culp EJ, Pallant D, Cook MA, Bonneil E, Thibault P, Wright GD, Tyers M. | Genetics | 10.1534/genetics.119.302851 | 2020 | |
| Enzymology | Comparison of the cobas 4800 CT/NG test with culture for detecting Neisseria gonorrhoeae in genital and nongenital specimens in a low-prevalence population in New Zealand. | Bromhead C, Miller A, Jones M, Whiley D. | J Clin Microbiol | 10.1128/jcm.03223-12 | 2013 | |
| Pathogenicity | Azithromycin resistance is coevolving with reduced susceptibility to cephalosporins in Neisseria gonorrhoeae in Ontario, Canada. | Allen VG, Seah C, Martin I, Melano RG. | Antimicrob Agents Chemother | 10.1128/aac.02608-13 | 2014 | |
| Pathogenicity | Prevalence of Neisseria gonorrhea and their antimicrobial susceptibility patterns among symptomatic women attending gynecology outpatient department in Hawassa referral hospital, Hawassa, Ethiopia. | Hailemariam M, Abebe T, Mihret A, Lambiyo T. | Ethiop J Health Sci | 2013 | | |
| Enzymology | Description of an unusual Neisseria meningitidis isolate containing and expressing Neisseria gonorrhoeae-Specific 16S rRNA gene sequences. | Walcher M, Skvoretz R, Montgomery-Fullerton M, Jonas V, Brentano S. | J Clin Microbiol | 10.1128/jcm.00309-13 | 2013 | |
| Direct molecular detection of amoxicillin-susceptible E. coli in urine samples from children with suspected urinary tract infection: A potential tool to improve antibiotic stewardship and patient care. | Slinger R, Dewpura T, Verma N, Bowes J, Barrowman N, Toye B. | J Assoc Med Microbiol Infect Dis Can | 10.3138/jammi.2019-0001 | 2019 | | |
| Phylogeny | Longitudinal analysis of the evolution and dissemination of Neisseria gonorrhoeae strains (Saskatchewan, Canada, 2005 to 2008) reveals three major circulating strains and convergent evolution of ciprofloxacin and azithromycin resistance. | Vidovic S, Thakur SD, Horsman GB, Levett PN, Anvari V, Dillon JA. | J Clin Microbiol | 10.1128/jcm.01402-12 | 2012 | |
| Enzymology | Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins. | Endimiani A, Guilarte YN, Tinguely R, Hirzberger L, Selvini S, Lupo A, Hauser C, Furrer H. | BMC Infect Dis | 10.1186/1471-2334-14-106 | 2014 | |
| Pathogenicity | Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells. | Brunati C, Thomsen TT, Gaspari E, Maffioli S, Sosio M, Jabes D, Lobner-Olesen A, Donadio S. | J Antimicrob Chemother | 10.1093/jac/dkx395 | 2018 | |
| Powerful Potential of Polyfluoroalkyl-Containing 4-Arylhydrazinylidenepyrazol-3-ones for Pharmaceuticals. | Burgart YV, Elkina NA, Shchegolkov EV, Krasnykh OP, Makhaeva GF, Triandafilova GA, Solodnikov SY, Boltneva NP, Rudakova EV, Kovaleva NV, Serebryakova OG, Ulitko MV, Borisevich SS, Gerasimova NA, Evstigneeva NP, Kozlov SA, Korolkova YV, Minin AS, Belousova AV, Mozhaitsev ES, Klabukov AM, Saloutin VI. | Molecules | 10.3390/molecules28010059 | 2022 | | |
| Pathogenicity | Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria. | Charrier C, Salisbury AM, Savage VJ, Duffy T, Moyo E, Chaffer-Malam N, Ooi N, Newman R, Cheung J, Metzger R, McGarry D, Pichowicz M, Sigerson R, Cooper IR, Nelson G, Butler HS, Craighead M, Ratcliffe AJ, Best SA, Stokes NR. | Antimicrob Agents Chemother | 10.1128/aac.02100-16 | 2017 | |
| Mutation in ribosomal protein S5 leads to spectinomycin resistance in Neisseria gonorrhoeae. | Ilina EN, Malakhova MV, Bodoev IN, Oparina NY, Filimonova AV, Govorun VM. | Front Microbiol | 10.3389/fmicb.2013.00186 | 2013 | | |
| Pathogenicity | Molecular characterization of quinolone-resistant Neisseria gonorrhoeae isolates from Brazil. | Uehara AA, Amorin EL, Ferreira Mde F, Andrade CF, Clementino MB, de Filippis I, Neves FP, Pinto Tde C, Teixeira LM, Giambiagi-Demarval M, Fracalanzza SE. | J Clin Microbiol | 10.1128/jcm.01175-11 | 2011 | |
| Development of a liposome microbicide formulation for vaginal delivery of octylglycerol for HIV prevention. | Wang L, Sassi AB, Patton D, Isaacs C, Moncla BJ, Gupta P, Rohan LC. | Drug Dev Ind Pharm | 10.3109/03639045.2011.637048 | 2012 | | |
| Enzymology | Bacterial etiology of ocular and periocular infections, antimicrobial susceptibility profile and associated factors among patients attending eye unit of Shashemene comprehensive specialized hospital, Shashemene, Ethiopia. | Mohammed AA, Ali MM, Zenebe MH. | BMC Ophthalmol | 10.1186/s12886-020-01398-w | 2020 | |
| Pathogenicity | Opportunity and means: horizontal gene transfer from the human host to a bacterial pathogen. | Anderson MT, Seifert HS. | mBio | 10.1128/mbio.00005-11 | 2011 | |
| Enzymology | Antineoplastic agents. 573. isolation and structure of papilistatin from the papilionid butterfly Byasa polyeuctes termessa. | Pettit GR, Ye Q, Herald DL, Hogan F, Pettit RK. | J Nat Prod | 10.1021/np9004689 | 2010 | |
| Pathogenicity | Emergence of quinolone resistance and cephalosporin MIC creep in Neisseria gonorrhoeae isolates from a cohort of young men in Kisumu, Kenya, 2002 to 2009. | Mehta SD, Maclean I, Ndinya-Achola JO, Moses S, Martin I, Ronald A, Agunda L, Murugu R, Bailey RC, Melendez J, Zenilman JM. | Antimicrob Agents Chemother | 10.1128/aac.00155-11 | 2011 | |
| Pathogenicity | Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone. | Lee SG, Lee H, Jeong SH, Yong D, Chung GT, Lee YS, Chong Y, Lee K. | J Antimicrob Chemother | 10.1093/jac/dkp505 | 2010 | |
| Pathogenicity | New statistical technique for analyzing MIC-based susceptibility data. | van de Kassteele J, van Santen-Verheuvel MG, Koedijk FD, van Dam AP, van der Sande MA, de Neeling AJ. | Antimicrob Agents Chemother | 10.1128/aac.05777-11 | 2012 | |
| Enzymology | Efficacy of a swab transport system in maintaining viability of Neisseria gonorrhoeae and Streptococcus pneumoniae. | Farhat SE, Thibault M, Devlin R. | J Clin Microbiol | 10.1128/jcm.39.8.2958-2960.2001 | 2001 | |
| Pathogenicity | Antimicrobial resistance of Neisseria gonorrhoeae and emerging ciprofloxacin resistance in the Netherlands, 1991 to 1998. | de Neeling AJ, van Santen-Verheuvel M, Spaargaren J, Willems RJ. | Antimicrob Agents Chemother | 10.1128/aac.44.11.3184-3185.2000 | 2000 | |
| Structural basis of peptidoglycan endopeptidase regulation. | Shin JH, Sulpizio AG, Kelley A, Alvarez L, Murphy SG, Fan L, Cava F, Mao Y, Saper MA, Dorr T. | Proc Natl Acad Sci U S A | 10.1073/pnas.2001661117 | 2020 | | |
| Pathogenicity | Susceptibilities of Neisseria gonorrhoeae to fluoroquinolones and other antimicrobial agents in Hyogo and Osaka, Japan. | Shigemura K, Okada H, Shirakawa T, Tanaka K, Arakawa S, Kinoshita S, Gotoh A, Kamidono S. | Sex Transm Infect | 10.1136/sti.2003.006908 | 2004 | |
| Pathogenicity | Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada. | Allen VG, Farrell DJ, Rebbapragada A, Tan J, Tijet N, Perusini SJ, Towns L, Lo S, Low DE, Melano RG. | Antimicrob Agents Chemother | 10.1128/aac.00788-10 | 2011 | |
| Enzymology | Rapid PCR detection of group A Streptococcus from flocked throat swabs: a retrospective clinical study. | Slinger R, Goldfarb D, Rajakumar D, Moldovan I, Barrowman N, Tam R, Chan F. | Ann Clin Microbiol Antimicrob | 10.1186/1476-0711-10-33 | 2011 | |
| Quality control limits for dilution and disk diffusion susceptibility tests of trovafloxacin against eight quality control strains. | Fuchs PC, Barry AL, Brown SD. | J Clin Microbiol | 10.1128/jcm.36.2.585-586.1998 | 1998 | | |
| Diagnostic efficacy of a real time-PCR assay for Chlamydia trachomatis infection in infertile women in north India. | Dhawan B, Rawre J, Ghosh A, Malhotra N, Ahmed MM, Sreenivas V, Chaudhry R. | Indian J Med Res | 2014 | | ||
| Preservation of Neisseria gonorrhoeae at -20 degrees C. | Harbec PS, Turcotte P. | J Clin Microbiol | 10.1128/jcm.34.5.1143-1146.1996 | 1996 | | |
| Pathogenicity | In vitro activities of ketolides HMR 3647 [correction of HRM 3647] and HMR 3004 [correction of HRM 3004], levofloxacin, and other quinolones and macrolides against Neisseria spp. and Moraxella catarrhalis. | Saez-Nieto JA, Vazquez JA. | Antimicrob Agents Chemother | 10.1128/aac.43.4.983 | 1999 | |
| Pathogenicity | Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae. | Takahata S, Senju N, Osaki Y, Yoshida T, Ida T. | Antimicrob Agents Chemother | 10.1128/aac.00626-06 | 2006 | |
| The laboratory diagnosis of Neisseria gonorrhoeae. | Ng LK, Martin IE. | Can J Infect Dis Med Microbiol | 10.1155/2005/323082 | 2005 | | |
| The Antimicrobial Properties of Cannabis and Cannabis-Derived Compounds and Relevance to CB2-Targeted Neurodegenerative Therapeutics. | Hong H, Sloan L, Saxena D, Scott DA. | Biomedicines | 10.3390/biomedicines10081959 | 2022 | | |
| A detailed analysis of 16S ribosomal RNA gene segments for the diagnosis of pathogenic bacteria. | Chakravorty S, Helb D, Burday M, Connell N, Alland D. | J Microbiol Methods | 10.1016/j.mimet.2007.02.005 | 2007 | | |
| Pathogenicity | Antineoplastic agents. 556. Isolation and structure of Coprinastatin 1 from Coprinus cinereus. | Pettit GR, Meng Y, Pettit RK, Herald DL, Cichacz ZA, Doubek DL, Richert L. | J Nat Prod | 10.1021/np900371j | 2010 | |
| Obtaining valid laboratory data in clinical trials conducted in resource diverse settings: lessons learned from a microbicide phase III clinical trial. | Crucitti T, Fransen K, Maharaj R, Tenywa T, Massinga Loembe M, Murugavel KG, Mendonca K, Abdellati S, Beelaert G, Van Damme L. | PLoS One | 10.1371/journal.pone.0013592 | 2010 | | |
| Pathogenicity | Interpretive criteria and quality control guidelines for Neisseria gonorrhoeae susceptibility test standardization for cefotetan. | Jones RN, Gerlach EH, Koontz FP, Murray PR, Pfaller MA, Washington JA, Erwin ME, Knapp CC. | J Clin Microbiol | 10.1128/jcm.29.2.363-366.1991 | 1991 | |
| Pathogenicity | Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases. | Stokes NR, Thomaides-Brears HB, Barker S, Bennett JM, Berry J, Collins I, Czaplewski LG, Gamble V, Lancett P, Logan A, Lunniss CJ, Peasley H, Pommier S, Price D, Smee C, Haydon DJ. | Antimicrob Agents Chemother | 10.1128/aac.00719-13 | 2013 | |
| Pathogenicity | High prevalence of high-level ciprofloxacin resistance in Neisseria gonorrhoeae in Tel Aviv, Israel: correlation with response to therapy. | Dan M, Poch F, Sheinberg B. | Antimicrob Agents Chemother | 10.1128/aac.46.6.1671-1673.2002 | 2002 | |
| Pathogenicity | Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin. | Knapp JS, Hale JA, Neal SW, Wintersheid K, Rice RJ, Whittington WL. | Antimicrob Agents Chemother | 10.1128/aac.39.11.2442 | 1995 | |
| Pathogenicity | Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains. | Ilina EN, Vereshchagin VA, Borovskaya AD, Malakhova MV, Sidorenko SV, Al-Khafaji NC, Kubanova AA, Govorun VM. | Antimicrob Agents Chemother | 10.1128/aac.01420-07 | 2008 | |
| Pathogenicity | In vitro susceptibilities of Neisseria gonorrhoeae to fatty acids and monoglycerides. | Bergsson G, Steingrimsson O, Thormar H. | Antimicrob Agents Chemother | 10.1128/aac.43.11.2790 | 1999 | |
| Phylogeny | Typing of Neisseria gonorrhoeae reveals rapid reinfection in rural South Africa. | Moodley P, Martin IM, Ison CA, Sturm AW. | J Clin Microbiol | 10.1128/jcm.40.12.4567-4570.2002 | 2002 | |
| Stilbenoids: A Natural Arsenal against Bacterial Pathogens. | Mattio LM, Catinella G, Dallavalle S, Pinto A. | Antibiotics (Basel) | 10.3390/antibiotics9060336 | 2020 | | |
| Evaluation of an immunochromatographic assay for the rapid and simultaneous detection of rotavirus and adenovirus in stool samples. | Kim J, Kim HS, Kim HS, Kim JS, Song W, Lee KM, Lee S, Park KU, Lee W, Hong YJ. | Ann Lab Med | 10.3343/alm.2014.34.3.216 | 2014 | | |
| Enzymology | Evaluation of the SD Bioline Norovirus rapid immunochromatography test using fecal specimens from Korean gastroenteritis patients. | Kim HS, Hyun J, Kim JS, Song W, Kang HJ, Lee KM. | J Virol Methods | 10.1016/j.jviromet.2012.08.014 | 2012 | |
| Pathogenicity | In vitro antibiotic susceptibility of Neisseria gonorrhoeae in Jakarta, Indonesia. | Lesmana M, Lebron CI, Taslim D, Tjaniadi P, Subekti D, Wasfy MO, Campbell JR, Oyofo BA. | Antimicrob Agents Chemother | 10.1128/aac.45.1.359-362.2001 | 2001 | |
| Pathogenicity | Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelines. | Jones RN, Gerlach EH, Koontz FP, Murray PR, Pfaller MA, Washington JA, Erwin ME, Knapp CC. | Diagn Microbiol Infect Dis | 10.1016/0732-8893(91)90065-n | 1991 | |
| Enzymology | Microbiological evaluation of the new VITEK 2 Neisseria-Haemophilus identification card. | Valenza G, Ruoff C, Vogel U, Frosch M, Abele-Horn M. | J Clin Microbiol | 10.1128/jcm.00953-07 | 2007 | |
| Survival of fastidious and nonfastidious aerobic bacteria in three bacterial transport swab systems. | Rishmawi N, Ghneim R, Kattan R, Ghneim R, Zoughbi M, Abu-Diab A, Turkuman S, Dauodi R, Shomali I, Issa Ael-R, Siriani I, Marzouka H, Schmid I, Hindiyeh MY. | J Clin Microbiol | 10.1128/jcm.02110-06 | 2007 | | |
| Pathogenicity | Susceptibilities of Neisseria gonorrhoeae isolates containing amino acid substitutions in GyrA, with or without substitutions in ParC, to newer fluoroquinolones and other antibiotics. | Tanaka M, Nakayama H, Haraoka M, Saika T, Kobayashi I, Naito S. | Antimicrob Agents Chemother | 10.1128/aac.44.1.192-195.2000 | 2000 | |
| Detection of respiratory viruses and bacteria in children using a twenty-two target reverse-transcription real-time PCR (RT-qPCR) panel. | Ellis C, Misir A, Hui C, Jabbour M, Barrowman N, Langill J, Bowes J, Slinger R. | World J Pediatr | 10.1007/s12519-015-0069-4 | 2016 | | |
| Pathogenicity | Detection of gyrA and parC mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by use of oligonucleotide biochip technology. | Zhou W, Du W, Cao H, Zhao J, Yang S, Li W, Shen Y, Zhang S, Du W, Zhang X. | J Clin Microbiol | 10.1128/jcm.42.12.5819-5824.2004 | 2004 | |
| Pathogenicity | In vitro activity of a new fluoroquinolone, CP-99,219, against strains of Neisseria gonorrhoeae. | Knapp JS, Neal SW, Parekh MC, Rice RJ. | Antimicrob Agents Chemother | 10.1128/aac.39.4.987 | 1995 | |
| Pathogenicity | Use of the National Committee for Clinical Laboratory Standards guidelines for disk diffusion susceptibility testing in New York state laboratories. | Kiehlbauch JA, Hannett GE, Salfinger M, Archinal W, Monserrat C, Carlyn C. | J Clin Microbiol | 10.1128/jcm.38.9.3341-3348.2000 | 2000 | |
| Enzymology | Rapid detection of Klebsiella pneumoniae from blood culture bottles by real-time PCR. | Kurupati P, Chow C, Kumarasinghe G, Poh CL. | J Clin Microbiol | 10.1128/jcm.42.3.1337-1340.2004 | 2004 | |
| Enzymology | Specific and sensitive detection of Neisseria gonorrhoeae in clinical specimens by real-time PCR. | Geraats-Peters CW, Brouwers M, Schneeberger PM, van der Zanden AG, Bruisten SM, Weers-Pothoff G, Boel CH, van den Brule AJ, Harmsen HG, Hermans MH. | J Clin Microbiol | 10.1128/jcm.43.11.5653-5659.2005 | 2005 | |
| Pathogenicity | Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug Administration. | Biedenbach DJ, Jones RN. | J Clin Microbiol | 10.1128/jcm.34.12.3214-3217.1996 | 1996 | |
| Pathogenicity | Disk diffusion method for susceptibility testing of Neisseria gonorrhoeae. | Ringertz S, Rylander M, Kronvall G. | J Clin Microbiol | 10.1128/jcm.29.8.1604-1609.1991 | 1991 | |
| Pathogenicity | Ofloxacin susceptibilities of 5,667 Neisseria gonorrhoeae strains isolated in Hong Kong. | Kam KM, Lo KK, Lai CF, Lee YS, Chan CB. | Antimicrob Agents Chemother | 10.1128/aac.37.9.2007 | 1993 | |
| Pathogenicity | Comparison of E test with agar dilution for antimicrobial susceptibility testing of Neisseria gonorrhoeae. | Van Dyck E, Smet H, Piot P. | J Clin Microbiol | 10.1128/jcm.32.6.1586-1588.1994 | 1994 | |
| Enzymology | Antineoplastic agents. 570. Isolation and structure elucidation of bacillistatins 1 and 2 from a marine Bacillus silvestris. | Pettit GR, Knight JC, Herald DL, Pettit RK, Hogan F, Mukku VJ, Hamblin JS, Dodson MJ, Chapuis JC. | J Nat Prod | 10.1021/np800603u | 2009 | |
| Pathogenicity | In vitro activity of gemifloxacin against recent clinical isolates of bacteria in Korea. | Yong DE, Cheong HJ, Kim YS, Park YJ, Kim WJ, Woo JH, Lee KW, Kang MW, Choo YS. | J Korean Med Sci | 10.3346/jkms.2002.17.6.737 | 2002 | |
| Cefaclor, an alternative to third generation cephalosporins for the treatment of gonococcal urethritis in the developing world? | Crabbe F, Grobbelaar TM, van Dyck E, Dangor Y, Laga M, Ballard RC. | Genitourin Med | 10.1136/sti.73.6.506 | 1997 | | |
| Pathogenicity | Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Hawaii. | Knapp JS, Ohye R, Neal SW, Parekh MC, Higa H, Rice RJ. | Antimicrob Agents Chemother | 10.1128/aac.38.9.2200 | 1994 | |
| Pathogenicity | Antimicrobial susceptibilities of Neisseria gonorrhoeae strains isolated in Surabaya, Indonesia. | Joesoef MR, Knapp JS, Idajadi A, Linnan M, Barakbah Y, Kamboji A, O'Hanley P, Moran JS. | Antimicrob Agents Chemother | 10.1128/aac.38.11.2530 | 1994 | |
| Pathogenicity | Susceptibility of Neisseria gonorrhoeae associated with pelvic inflammatory disease to cefoxitin, ceftriaxone, clindamycin, gentamicin, doxycycline, azithromycin, and other antimicrobial agents. | Rice RJ, Knapp JS. | Antimicrob Agents Chemother | 10.1128/aac.38.7.1688 | 1994 | |
| Pathogenicity | Evaluation of Etest for testing antimicrobial susceptibilities of Neisseria gonorrhoeae isolates with different growth media. | Yeung KH, Ng LK, Dillon JA. | J Clin Microbiol | 10.1128/jcm.31.11.3053-3055.1993 | 1993 | |
| Evaluation of a new cellulose sponge-tipped swab for microbiological sampling: a laboratory and clinical investigation. | Osterblad M, Jarvinen H, Lonnqvist K, Huikko S, Laippala P, Viljanto J, Arvilommi H, Huovinen P. | J Clin Microbiol | 10.1128/jcm.41.5.1894-1900.2003 | 2003 | | |
| Pathogenicity | Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. | Zarantonelli L, Borthagaray G, Lee EH, Shafer WM. | Antimicrob Agents Chemother | 10.1128/aac.43.10.2468 | 1999 | |
| Pathogenicity | Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. | Ng LK, Martin I, Liu G, Bryden L. | Antimicrob Agents Chemother | 10.1128/aac.46.9.3020-3025.2002 | 2002 | |
| Pathogenicity | Susceptibility of Neisseria gonorrhoeae to cefpodoxime: determination of MICs and disk diffusion zone diameters. | Fekete T, Woodwell J, Cundy KR. | Antimicrob Agents Chemother | 10.1128/aac.35.3.497 | 1991 | |
| Antineoplastic agents. 548. Synthesis of iodo- and diiodocombstatin phosphate prodrugs. | Pettit GR, Rosenberg HJ, Dixon R, Knight JC, Hamel E, Chapuis JC, Pettit RK, Hogan F, Sumner B, Ain KB, Trickey-Platt B. | J Nat Prod | 10.1021/np200797x | 2012 | | |
| Pathogenicity | Antimicrobial activity of DC-159a, a new fluoroquinolone, against 1,149 recently collected clinical isolates. | Jones RN, Fritsche TR, Sader HS. | Antimicrob Agents Chemother | 10.1128/aac.00294-08 | 2008 | |
| Antineoplastic agents. 560. Isolation and structure of kitastatin 1 from an Alaskan Kitasatospora sp. | Pettit GR, Tan R, Pettit RK, Smith TH, Feng S, Doubek DL, Richert L, Hamblin J, Weber C, Chapuis JC. | J Nat Prod | 10.1021/np068072c | 2007 | | |
| Enzymology | Rapid identification of bacteria from positive blood cultures by terminal restriction fragment length polymorphism profile analysis of the 16S rRNA gene. | Christensen JE, Stencil JA, Reed KD. | J Clin Microbiol | 10.1128/jcm.41.8.3790-3800.2003 | 2003 | |
| Pathogenicity | Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar medium. | Erwin ME, Jones RN. | J Clin Microbiol | 10.1128/jcm.30.5.1170-1173.1992 | 1992 | |
| Pathogenicity | Evaluation of the standardized disk diffusion and agar dilution antibiotic susceptibility test methods by using strains of Neisseria gonorrhoeae from the United States and Southeast Asia. | Putnam SD, Lavin BS, Stone JR, Oldfield EC, Hooper DG. | J Clin Microbiol | 10.1128/jcm.30.4.974-980.1992 | 1992 | |
| Pathogenicity | In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency. | Huband MD, Cohen MA, Meservey MA, Roland GE, Yoder SL, Dazer ME, Domagala JM. | Antimicrob Agents Chemother | 10.1128/aac.37.12.2563 | 1993 | |
| Pathogenicity | In vitro activities of clinafloxacin against contemporary clinical bacterial isolates from 10 North American centers. | Fuchs PC, Barry AL, Brown SD. | Antimicrob Agents Chemother | 10.1128/aac.42.5.1274 | 1998 | |
| Pathogenicity | Antimicrobial susceptibility testing of Neisseria gonorrhoeae and implications for epidemiology and therapy. | Fekete T. | Clin Microbiol Rev | 10.1128/cmr.6.1.22 | 1993 | |
| Phylogeny | Detection and identification of Mycobacterium species isolates by DNA microarray. | Fukushima M, Kakinuma K, Hayashi H, Nagai H, Ito K, Kawaguchi R. | J Clin Microbiol | 10.1128/jcm.41.6.2605-2615.2003 | 2003 | |
| Pathogenicity | Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone. | Visser MR, Rozenberg-Arska M, Beumer H, Hoepelman IM, Verhoef J. | Antimicrob Agents Chemother | 10.1128/aac.35.5.858 | 1991 | |
| Genetics | Validation and Implementation of Clinical Laboratory Improvements Act-Compliant Whole-Genome Sequencing in the Public Health Microbiology Laboratory. | Kozyreva VK, Truong CL, Greninger AL, Crandall J, Mukhopadhyay R, Chaturvedi V. | J Clin Microbiol | 10.1128/jcm.00361-17 | 2017 | |
| Pathogenicity | The cephalostatins. 21. Synthesis of bis-steroidal pyrazine rhamnosides (1). | Pettit GR, Mendonca RF, Knight JC, Pettit RK. | J Nat Prod | 10.1021/np200411p | 2011 | |
| Antineoplastic agents. 515. Synthesis of human cancer cell growth inhibitors derived from 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene. | Pettit GR, Anderson CR, Gapud EJ, Jung MK, Knight JC, Hamel E, Pettit RK. | J Nat Prod | 10.1021/np058033l | 2005 | | |
| Evaluation of the analytical performance of the Xpert MTB/RIF assay. | Blakemore R, Story E, Helb D, Kop J, Banada P, Owens MR, Chakravorty S, Jones M, Alland D. | J Clin Microbiol | 10.1128/jcm.00128-10 | 2010 | | |
| Antineoplastic agents. 565. Synthesis of combretastatin D-2 phosphate and dihydro-combretastatin D-2. | Pettit GR, Quistorf PD, Fry JA, Herald DL, Hamel E, Chapuis JC. | J Nat Prod | 10.1021/np800635h | 2009 | | |
| Phylogeny | Detection and characterization of human Ureaplasma species and serovars by real-time PCR. | Xiao L, Glass JI, Paralanov V, Yooseph S, Cassell GH, Duffy LB, Waites KB. | J Clin Microbiol | 10.1128/jcm.01877-09 | 2010 | |
| Biotechnology | Detection of Salmonella spp. in oysters by PCR. | Bej AK, Mahbubani MH, Boyce MJ, Atlas RM. | Appl Environ Microbiol | 10.1128/aem.60.1.368-373.1994 | 1994 | |
| Pathogenicity | In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae. | Allen GP, Deao KM, Hill SA, Schipelliti SM, Tran T | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2021.106417 | 2021 | |
| In Vitro and In Vivo Activities of TP0480066, a Novel Topoisomerase Inhibitor, against Neisseria gonorrhoeae. | Masuko A, Takata I, Fujita K, Okumura H, Ushiyama F, Amada H, Sugiyama H | Antimicrob Agents Chemother | 10.1128/AAC.02145-20 | 2021 | | |
| Pathogenicity | Octenidine/carbenicillin GUMBOS as potential treatment for oropharyngeal gonorrhoea. | Lopez KM, Hobden JA, Warner IM | J Antimicrob Chemother | 10.1093/jac/dkaa346 | 2020 | |
| Metabolism | Comparative Proteomics of Extended-Spectrum Cephalosporin-Resistant Neisseria gonorrhoeae Isolates Demonstrates Altered Protein Synthesis, Metabolism, Substance Transport, and Membrane Permeability. | Diao N, Yan G, Yang Y, Dong Y, Wang Y, Gu W | Front Microbiol | 10.3389/fmicb.2020.00169 | 2020 | |
| Cultivation | Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor Zoliflodacin. | Miller AA, Traczewski MM, Huband MD, Bradford PA, Mueller JP | J Clin Microbiol | 10.1128/JCM.00567-19 | 2019 | |
| Genetics | Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan. | Jabeen K, Bhawan Mal P, Khan E, Chandio S, Jacobsson S, Unemo M | BMC Infect Dis | 10.1186/s12879-016-1673-1 | 2016 | |
| Pathogenicity | Multicenter Investigation of Gepotidacin (GSK2140944) Agar Dilution Quality Control Determinations for Neisseria gonorrhoeae ATCC 49226. | Jones RN, Fedler KA, Scangarella-Oman NE, Ross JE, Flamm RK | Antimicrob Agents Chemother | 10.1128/AAC.00527-16 | 2016 | |
| Pathogenicity | In vitro potency and combination testing of antimicrobial agents against Neisseria gonorrhoeae. | Bharat A, Martin I, Zhanel GG, Mulvey MR | J Infect Chemother | 10.1016/j.jiac.2015.10.002 | 2015 | |
| Pathogenicity | Determination of Disk Diffusion and MIC Quality Control Guidelines for Solithromycin, a Novel Fluoroketolide Antibacterial, against Neisseria gonorrhoeae. | Riedel S, Ross JE, Farrell DJ, Flamm RK, Jones RN | J Clin Microbiol | 10.1128/JCM.02250-15 | 2015 | |
| Pathogenicity | In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates. | Hauser C, Hirzberger L, Unemo M, Furrer H, Endimiani A | Antimicrob Agents Chemother | 10.1128/AAC.04536-14 | 2014 | |
| Pathogenicity | Coupling electrochemical response of a DNA biosensor with PCR for Neisseria gonorrhoeae detection. | Verma R, Sood S, Singh R, Sumana G, Bala M, Sharma VK, Samantaray JC, Pandey RM, Malhotra BD | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2013.09.010 | 2013 | |
| Pathogenicity | Non-cytotoxic nanomaterials enhance antimicrobial activities of cefmetazole against multidrug-resistant Neisseria gonorrhoeae. | Li LH, Yen MY, Ho CC, Wu P, Wang CC, Maurya PK, Chen PS, Chen W, Hsieh WY, Chen HW | PLoS One | 10.1371/journal.pone.0064794 | 2013 | |
| Increasing Trend of Resistance to Penicillin, Tetracycline, and Fluoroquinolone Resistance in Neisseria gonorrhoeae from Pakistan (1992-2009). | Jabeen K, Nizamuddin S, Irfan S, Khan E, Malik F, Zafar A | J Trop Med | 10.1155/2011/960501 | 2011 | | |
| Pathogenicity | Resistance to azithromycin of Neisseria gonorrhoeae isolates from 2 cities in China. | Yuan LF, Yin YP, Dai XQ, Pearline RV, Xiang Z, Unemo M, Chen XS | Sex Transm Dis | 10.1097/OLQ.0b013e318219cdb5 | 2011 | |
| Pathogenicity | Evaluation of the mutant selection window for fluoroquinolones against Neisseria gonorrhoeae. | Allen GP, Hankins CD | J Antimicrob Chemother | 10.1093/jac/dkp172 | 2009 | |
| Enzymology | In vitro antigonococcal activity of Coscinium fenestratum stem extract. | Chomnawang MT, Trinapakul C, Gritsanapan W | J Ethnopharmacol | 10.1016/j.jep.2009.01.036 | 2009 | |
| Cultivation | Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control. | Brown SD, Traczewski MM | J Clin Microbiol | 10.1128/JCM.02351-06 | 2007 | |
| Pathogenicity | Studies on antimicrobial activity, in vitro, of Physalis angulata L. (Solanaceae) fraction and physalin B bringing out the importance of assay determination. | Silva MT, Simas SM, Batista TG, Cardarelli P, Tomassini TC | Mem Inst Oswaldo Cruz | 10.1590/s0074-02762005000700018 | 2006 | |
| Phylogeny | Evaluation of the BIOCEN GC agar medium base in antimicrobial susceptibility testing of Neisseria gonorrhoeae. | Llanes R, Dominguez C, Prat A, Rodriguez C, Valdes EA, Gutierrez O, Guzman D | Arch Med Res | 10.1016/j.arcmed.2005.03.011 | 2005 | |
| Pathogenicity | Development of gemifloxacin in vitro susceptibility test methods for gonococci including quality control guidelines. The Quality Control Study Group. | Jones RN, Erwin ME | Diagn Microbiol Infect Dis | 10.1016/s0732-8893(00)00139-5 | 2000 | |
| Pathogenicity | [Antimicrobial susceptibility of Neisseria gonorrhoeae strains determined by disk diffusion]. | Llanes Caballero R, Acosta Giraldo JC, Sosa Puente J, Guzman Hernandez D, Gutierrez Gonzalez O, Llop Hernandez A | Rev Cubana Med Trop | 1999 | | |
| Pathogenicity | Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Results from multicenter trials. | Worth S, Erwin ME, Jones RN | Diagn Microbiol Infect Dis | 10.1016/0732-8893(95)00276-6 | 1996 | |
| Pathogenicity | Tentative interpretive criteria and quality control parameters for in-vitro susceptibility testing of Neisseria gonorrhoeae to two fluoroquinolones (PD 131628 and grepafloxacin (OPC 17116)). | Sewell DL, Barry AL, Allen SD, Fuchs PC, Murray PR, Tenover FC | J Antimicrob Chemother | 10.1093/jac/37.1.139 | 1996 | |
| Pathogenicity | Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study Group. | Bale MJ, Jones RN, Erwin ME | Diagn Microbiol Infect Dis | 10.1016/0732-8893(94)90054-x | 1994 | |
| Pathogenicity | Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group. | Bale MJ, Jones RN | J Clin Microbiol | 10.1128/jcm.31.9.2538-2540.1993 | 1993 | |
| Pathogenicity | Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters. | Barry AL, Fuchs PC, Allen SD, Jorgensen JH, Tenover FC, Murray PR, Hardy DJ, Baker CN | J Clin Microbiol | 10.1128/jcm.31.9.2375-2380.1993 | 1993 | |
| Pathogenicity | Proposed interpretive criteria and quality control parameters for testing susceptibility of Neisseria gonorrhoeae to beta-lactam-clavulanate combinations. | Fuchs PC, Barry AL, Baker CN, Murray PR, Washington JA | J Clin Microbiol | 10.1128/jcm.30.8.2191-2194.1992 | 1992 | |
| Pathogenicity | MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin. | Erwin ME, Jones RN, Koontz FP, Gerlach EH, Murray PR, Washington JA | J Clin Microbiol | 10.1128/jcm.30.5.1317-1319.1992 | 1992 | |
| Pathogenicity | Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacin. | Barry AL, Cohen MA, Sesnie JC, Fuchs PC, Washington JA, Murray PR, Baker C | J Clin Microbiol | 10.1128/jcm.30.4.813-816.1992 | 1992 | |
| Pathogenicity | Proposed interpretive criteria and quality control parameters for ofloxacin susceptibility testing of Neisseria gonorrhoeae. | Fuchs PC, Barry AL, Baker C, Murray PR, Washington JA | J Clin Microbiol | 10.1128/jcm.30.4.1024-1026.1992 | 1992 | |
| Pathogenicity | Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin. | Fuchs PC, Barry AL, Baker C, Murray PR, Washington JA 2nd | J Clin Microbiol | 10.1128/jcm.29.10.2111-2114.1991 | 1991 | |
| Cultivation | Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline. | Jones RN, Gavan TL, Thornsberry C, Fuchs PC, Gerlach EH, Knapp JS, Murray P, Washington JA 2nd | J Clin Microbiol | 10.1128/jcm.27.12.2758-2766.1989 | 1989 | |
| Pathogenicity | Antimicrobial Activity of Auranofin, Cannabidivarin, and Tolfenamic Acid against Multidrug-Resistant Neisseria gonorrhoeae. | Yang F, Liu J, Gu Y, Jiao R, Yan J, Gao S, Lin X, van der Veen S | Microbiol Spectr | 10.1128/spectrum.03952-22 | 2022 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive10471.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License